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Overview 
This thesis focuses on exploring similarities between obsessive compulsive disorder 
(OCD) and autism spectrum disorders (ASD).  Part 1 reviews research literature 
examining the overlap of symptomatology and traits across the disorders.  The 
reviewed studies provide evidence for elevated levels of ASD traits in some 
individuals with OCD and vice versa with variable results as to which specific traits 
this applies.  None of the reviewed studies provides sufficient evidence to support or 
refute explanations for the nature of this apparent overlap in traits across disorders.  
Part 2 reports an investigation into autistic cognition in a population of adults with 
OCD in relation to their self-reported autistic traits. Although the study provides 
some tentative evidence for some individuals with OCD having neurodevelopmental 
aetiology (e.g. atypical neurocognitive performances), group and multiple single case 
series analysis failed to identify relationships between autistic cognition and autistic 
traits at group and individual levels respectively.  Whether the apparent elevation of 
self-reported autistic traits identified in this OCD population represents genuine ASD 
symptomatology is unclear and explanations for these ambiguous results are 
proposed together with directions for future research.  This investigation formed part 
of a joint study with Josselyn Hellriegel (trainee clinical psychologist, UCL) 
(Hellriegel, 2014). 
Part 3 discusses some of the practical, methodological and ethical complexities 
inherent in conducting research with a clinical population with significant mental 
health difficulties such as OCD, including challenges in recruitment, risk 
management and neurocognitive assessment. The importance of flexibility both in 
research design and analysis is emphasised. Benefits of employing multiple single 
case series analysis in heterogeneous populations such as OCD are highlighted. 
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Abstract 
Aim 
To review current evidence for the overlap in symptomatology and traits of 
obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD). 
Method  
A systematic search of online databases, PubMed and PsycINFO, and 
searching reference lists and citations of all relevant articles identified 16 studies 
meeting quality and relevance criteria for review.  
Results  
Research was categorised into four sections according to the key research 
questions and participants included: (1) OCD symptomatology in ASD populations; 
(2) ASD symptomatology in OCD populations; (3) OCD and ASD symptomatology 
within families; and (4) OCD and ASD symptomatology in non-clinical populations. 
The studies provide consistent evidence for the apparent existence of at least sub-
clinical levels of ASD symptomatology in some individuals with OCD and vice 
versa, with variable results as to which specific symptoms this applies.   
Conclusions 
The review considers and finds inadequate evidence to support or refute three 
possible explanatory models for the identified elevation of traits across disorders; 
comorbidity, genuine symptom overlap and superficial symptom overlap. Measures 
of symptomatology employed struggled to discriminate adequately between specific 
diagnostic constructs.  The studies highlight the need for clinicians to be mindful that 
repetitive behaviours in ASD may not be ego-syntonic and may cause as much 
distress as those similar repetitive behaviours seen in OCD.  
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Introduction 
Obsessive compulsive disorder (OCD) is defined as a disorder where the 
repeated occurrence of obsessions and/or compulsions is of sufficient severity that 
they are time-consuming (> 1 hour per day) or cause marked distress or discomfort 
(American Psychiatric Association (APA), 2013). It has an estimated lifetime 
prevalence of between 1% and 2% of the general population (Clark, 2004), occurring 
slightly more in women than in men (Andrews, Henderson & Hall, 2001).  It tends to 
take a chronic course with spontaneous remission being rare (Skoog & Skoog, 1999) 
and impacts negatively on daily living and personal attainment. 
Autism spectrum disorder (ASD) is a neurodevelopmental disorder 
characterised by impaired communication and social interaction, repetitive 
behaviours and restricted interests (APA, 2013; World Health Organisation, 1992). 
Thus similarly to OCD, core symptoms of ASD are repetitive behaviour and 
compulsivity.  It is a lifelong disorder with an estimated prevalence of 1% of the 
population and affects three times more males than females (Baird et al. 2006; 
Chakrabarti, & Fombonne, 2001). 
The DSM-IV classified OCD as an anxiety disorder (APA, 2000) and as a 
unitary diagnostic entity. However, under DSM-5 OCD is classified not as an anxiety 
disorder but under ‘Obsessive Compulsive and Related Disorders’, with related 
diagnoses including body dysmorphic disorder, hoarding disorder, trichotillomania 
and skin picking disorder (APA, 2013).  This change of classification followed 
increasing evidence to support the heterogeneity of symptoms which fall under an 
OCD diagnosis and the growing number of clinical researchers challenging the 
prevailing view of OCD as an anxiety disorder (Clark, 2004), a key argument being 
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that obsessions and compulsions, rather than anxiety, are the fundamental features of 
the disorder (Mataix-Cols, Pertusa & Leckman, 2007).  It has been posited that 
possible differences in the biochemistry between OCD and other anxiety disorders 
and greater functional impairment in OCD exist (Enright, 1996).  In addition, 
Hollander, Kim, Khanna and Pallanti (2007) noted that the neurocircuitry of OCD 
and anxiety disorders differ in that OCD demonstrates dysfunction in the frontal-
striatal circuitry whilst anxiety disorders involve the amygdala and a fear response.  
This literature review forms part of an ongoing debate as to whether OCD is 
an anxiety disorder, whether it is better defined as a neurodevelopmental disorder or 
whether within OCD both a neurodevelopmental and an anxiety subgroup exist.  This 
debate is fueled by evidence suggesting that, despite significant progress in the 
efficacy of interventions for OCD, approximately 50% of patients remain clinically 
unwell following a drop out from or a limited response to recommended intervention 
(Abramowitz, 2006).  Some suggest that the focus of research into OCD as an 
anxiety disorder characterised by harm avoidance (Calamari et al. 2006) at the 
expense of research into OCD motivated by feelings of incompleteness, may explain 
a lack of effective treatment for a large percentage of those with an OCD diagnosis 
(Ecker & Gonner, 2008). 
Personality disorders and traits have also been emphasised as important in the 
treatment outcome of OCD (Bejerot, Nylander & Lindstrom, 2001). Specifically 
there is evidence that the presence of cluster A personality disorder (odd and 
eccentric), obsessive compulsive personality disorder, or total number of personality 
disorders are predictive of a poorer outcome in OCD (Baer et al. 1992; Cavedini, 
Erzegovesi, Ronchi, & Bellodi, 1997; MiniChiello, Baer & Jenike, 1987).  Bejerot et 
al. (2001) suggested that a proportion of those classified with comorbid personality 
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disorder may in fact be individuals with high functioning ASD and noted that the 
negative predictors of treatment outcome of OCD are strikingly similar to 
characteristics common in ASD.  For example, males living alone (Buchanan, Meng 
& Marks, 1996), difficulties with interpersonal relations (Fals-Stewart & Lucente, 
1993), hoarding (Black et al. 1998), abnormal personality, social impairment, and 
childlessness (de Silva, Rachman, & Seligman, 1977) have all been found to be 
negative predictors in treatment outcome of OCD. 
Consistent with Bejerot et al.’s (2001) theoretical proposition is the 
phenomenological overlap of some OCD symptoms with ASD. Many OCD patients 
are characterised by repetitive behaviours (similar to those observed in ASD). In 
OCD, many patients have ordering and symmetry compulsions, as well as repetition 
compulsions and a desire to achieve a “just right” feeling (Rapoport, 1989; 
Rasmussen & Eisen, 1992), which is often thought of as a particular OCD symptom 
dimension, i.e. “Symmetry and Ordering” (Baer, 1994).  The overlap of symptom 
presentation at a phenomenological level appears striking.  There is however a 
common assumption that these repetitive behaviours differ between disorders in that 
the repetitive behaviours of OCD are ego-dystonic (in conflict with the needs and 
goals of the ego or preferred identify of the individual) and as such cause distress, 
whereas the repetitive behaviours of ASD are ego-syntonic and as such do not cause 
the individual significant distress (Paula-Perez, 2013).  
One study of children and adolescents with OCD found that half had low 
levels of activity and sociability and high levels of shyness (Ivarsson & 
WingeWestholm, 2004) and hypothesised that some of these individuals might have 
ASD traits. In the same study, the other half showed normal levels of activity and 
sociability, high levels of emotionality and low levels of shyness, perhaps more akin 
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to an anxiety disorder.  ASD and OCD have also been found to be comorbid at a 
higher level than in the normal population (Williams, Higgins & Brayne, 2006).  
Thus, within the larger debate as to whether OCD is better defined as an anxiety or 
neurodevelopmental disorder, there is a question as to the relationship between OCD 
and ASD.  
 In light of the recent focus on and changes in conceptualisation of OCD, the 
similarities between OCD and ASD have fostered curiosity about the possibility of 
overlap.  Numerous studies have investigated rates of comorbidity between the two 
disorders, a recent meta-analysis summarising these studies found 17.4% of 
individuals with ASD had comorbid OCD (van Steensel, Bögels & Perrin, 2011).  
However, these prevalence studies do not provide details regarding the quality of the 
symptoms measured; the possibility that elevated rates of comorbidity in fact reflect 
measurement error or symptom overlap requires a deeper analysis. Indeed, 
discriminating between superficial or genuine symptom overlap is a challenge in 
symptom focussed research and dependent on the specificity of measures of 
symptomatology employed.  This challenge is exacerbated by the possible 
comorbidity of the two disorders.  
There has been emerging research into whether OCD and ASD are 
interrelated and the nature of this relationship at a symptom level. Specifically some 
studies have focussed on OCD symptomatology in ASD, some on ASD 
symptomatology in OCD and others on shared symptomatology in the general 
population, or relatives of probands with one of the disorders, using symptom 
measures with proven psychometric value.  If there is an overlap of symptomatology 
or, as Bejerot et al. (2001) suggest, a subgroup of individuals with a diagnosis of 
OCD who actually have high functioning ASD, it will be important to understand 
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further the nature of the relationship between the two disorders and how available 
measurement tools can support this understanding in order to inform better treatment 
packages for the individuals.   
The current review 
The purpose of this review is to summarise and critically evaluate studies that 
have investigated empirically the overlap in the symptomatology or traits of OCD 
and ASD in order to address two key aims: 
1. To investigate whether there is an overlap between ASD and OCD, by 
considering whether OCD symptoms are more common than would be 
expected by chance amongst people with ASD and vice versa. 
2. To provide insight into whether any observed symptom overlap reflects 
comorbidity, aetiological factors shared between OCD and ASD, or 
measurement error whereby distinct symptoms of one disorder bear a 
superficial similarity to those of another. 
No previous reviews published in this area have systematically reviewed the 
overlap between the full range of ASD and OCD symptoms.  Previous work in this 
area has tended to be non-systematic (Paula-Perez, 2013), or to focus only on an 
incomplete range of OCD / ASD symptoms (Chasson et al. 2011; Paula-Perez, 2013) 
or has failed to include and systematically review research into ASD symptoms in 
OCD (Fischer-Terworth & Probst, 2009). In addition, there have been a number of 
papers published in recent years which would not have been included in previous 
reviews.   
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Method 
Search strategy 
Articles were retrieved through (a) searching PubMed and PsycINFO 
electronic databases and (b) searching reference lists and citations of all relevant 
articles. No year limits were placed. Searches were restricted to English language 
articles with human subjects.  
Search terms  
The search focused on two domains in combination:  
1) Obsessive compulsive disorder and 2) Autistic spectrum disorders.   
An initial scope of the literature was conducted in order to identify relevant search 
terms. Based on this, the search terms presented below in table 1 were used. 
Table 1: Literature review search terms 
Any of following terms for obsessive 
compulsive disorder  
Combined 
with   “AND” 
Any of following terms for autistic 
spectrum disorders  
Obsessive Compulsive Disorder* or 
Obsess* or 
Compuls* or 
OCD or 
"Obsessive compulsive symptoms" or 
"Obsession* and Compulsion*" or 
"obsessive-compulsive"  
 
 ASD or 
Autism Spectrum Disorder* or 
Autis* or 
Asperg* or 
HFA or 
"High Functioning Autism" or 
"High-Functioning-Autism" or 
"Autism-spectrum" or 
Autistic 
* Indicates that terms were truncated to allow for multiple word endings. 
Phrases in quotation marks indicate that word streams were taken as a whole to 
search for specific phrases. 
 
The search was designed to identify only those studies with at least one 
search term from each of the two domains in the title, abstract or as a keyword.  
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Searches of PsycINFO and PubMed yielded 665 and 406 results respectively, with 
much overlap in these results. 
Selection strategy 
The titles and abstracts of all articles identified by electronic searches were 
screened by the author to exclude duplicates and to evaluate the studies against the 
following inclusion criteria: 
Inclusion criteria 
The following criteria were used to determine whether a study should be included 
in the review: 
 The article related to humans and was published in English, in a peer-
reviewed journal to control for quality; 
 The study measured OCD symptoms in a population with a diagnosis of 
autism or autism probands using at least one OCD measure with proven 
psychometric value, that is measures which have published information 
evidencing satisfactory reliability and validity, OR 
 The study measured ASD symptoms in a population with a diagnosis of OCD 
or OCD probands using at least one ASD measure with proven psychometric 
value, OR  
 The study measured symptomatology of both ASD and OCD in a non-clinical 
population using at least one measure of ASD with proven psychometric 
value and one measure of OCD with proven psychometric value. 
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Study selection process 
Figure 1 shows the study selection process.  The electronic search returned a 
total of 803 studies. Studies were first screened by titles and abstracts resulting in a 
list of 44 potentially eligible studies, the manuscripts of which were examined in full.  
Many articles were excluded at the stage of scanning abstracts because they clearly 
did not meet one or more of the inclusion criteria e.g. studies which focused on OCD 
but not ASD, ASD but not OCD or neither disorder (N=363); single case studies 
(N=70); studies focussing on the efficacy of an intervention on the reduction of 
symptoms rather than on gathering symptom specific information (N=57); articles 
presenting theoretical models, review articles or meta-analyses which did not present 
original data (N=169); studies detailing comorbidity or prevalence rates rather than 
reporting on specific symptoms of the disorders (N=22); studies exploring ASD and 
OCD which did not present symptom-level data but rather focused on genetic, 
neurocognitive, biological or other factors (N=72); and studies using measures of 
symptoms of OCD or ASD without proven psychometric value (N=6).   
Fifteen of the 44 potentially eligible studies met all the inclusion criteria. The 
29 studies excluded at this stage either used measures of symptoms of OCD or ASD 
without proven psychometric value (N=3); focussed on comorbidity or prevalence 
rates rather than reporting on specific symptoms of the disorders (N=10); focussed 
not on symptom-level data, but on genetic, biological, neurocognitive or other factors 
(N=7); presented theoretical models, were review articles or meta-analyses which did 
not present original data (N=5); focussed on ASD but not OCD (N=3); or focussed 
on the efficacy of an intervention not symptomatology (N=1).  An additional study 
was identified through citation searching.  In total 16 studies were included in the 
review. 
 18 
Figure 1: Study selection flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
803 studies identified 
from initial search  
(658 from PsycINFO and 
145 from PubMed) 
44 studies examined 
closely in full 
15 studies met all 
inclusion criteria 
 759 studies excluded 
on basis of titles and 
abstracts. 
29 studies excluded due to: 
- Use of measures of 
symptomatology 
without proven 
psychometric value 
(N=3) 
 
- Focus on comorbidity 
or prevalence rates 
rather than reporting 
on specific symptoms 
of the disorders 
(N=10) 
 
- Focus not on 
symptom-level data, 
but on genetic, 
biological, 
neurocognitive or other 
factors (N=7) 
 
- Theoretical models, 
review articles or 
meta-analyses which 
do not present original 
data (N=5). 
 
- Focus on ASD but not 
OCD (N=3) 
 
- Focus on the efficacy 
of an intervention not 
symptomatology 
(N=1) 
16 studies included in the 
review 
 
1 study 
identified 
from citation 
searching 
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Results: 
A summary of the 16 studies included is presented in Table 2.  The studies are 
categorised into four sections according to the key research questions and 
participants included: (1) OCD symptomatology in ASD populations which includes 
ten studies; (2) ASD symptomatology in OCD populations which includes 5 studies; 
(3) OCD and ASD symptomatology within families which includes 2 studies; and (4) 
OCD and ASD symptomatology in non-clinical populations which includes 1 study.  
Two studies explored both ASD symptomatology in OCD populations and OCD 
symptomatology in ASD populations and as such are included in both sections 1 and 
2.  Table 3 describes the measures employed by research included in this review. 
2
0
 
 
Table 2: Summary table of reviewed studies 
Author Populations (N) Diagnostic instrument (delivered 
by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Obsessive Compulsive symptoms and traits in populations with ASD 
McDougle 
et al. 1995 
1. Adults with ASD-(50) 
2. Adults with OCD-(50) 
Groups recruited from 
specialist clinics –
Diagnosis not 
independently verified. 
 
 Groups matched for age 
and gender. 
 OCD group excluded 
those with mental 
retardation or borderline 
intellectual functioning. 
 Excluded if history of 
other significant 
neurological or medical 
illnesses. 
 All participants- 
medication free at time 
of study. 
 
OCD symptomatology: 
 The YBOCS-(not 
specified) 
 
Types of repetitive thoughts and 
behaviour in adults with OCD 
vs. ASD are significantly 
different. 
 
Russell 
Mataix-
Cols, Anson 
& Murphy,  
2005 
1. Adults with HFA-(40) 
2. Adults with OCD-(45) 
Groups recruited from 
specialist clinics 
1. Psychiatric interview 
(Psychiatrist)+ 58% ADI. 
2. Psychiatric interview 
(Psychiatrist). 
 Matched for gender 
 Excluded if IQ<70, 
comorbid psychosis 
and/or substance 
misuse. 
 
OCD symptomatology: 
 YBOCS-
(experienced 
clinician). 
 Obsessions and 
compulsions, which are 
distressing and time-
consuming, are common in 
adults with HFA. 
 Types of obsessions and 
compulsions are similar. 
  
2
1
 
Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
*Zandt, 
Prior, & 
Kyrios,  
2007 
1. Children with autism-
(19) 
2. Children with OCD-
(17) 
3. TD children-(18) 
 Clinical interview with 
parents and children 
including language and 
cognitive assessments– 
(experienced professionals). 
 Excluded if comorbid 
neurological disorder, 
intellectual disability, 
language disorder 
and/or Axis 1 disorder. 
 Verbal and performance 
IQ measured (WISC-
III). 
ASD symptomatology: 
 RBQ (parental-
report) 
 
OCD symptomatology: 
 CYBOCS – 
(Clinical 
Psychologist) 
 
 Similar levels of sameness 
behaviours and repetitive 
movements in two clinical 
groups. 
 Suggests types of 
behaviours differ between 
the groups; obsessions and 
compulsions being less 
sophisticated in ASD 
group.  
 
 
*Cath, Ran, 
Smit, van-
Balkom & 
Comjis, 
2008 
1. Adults with ASD-(12) – 
(a) with comorbid 
OCD-(6) 
(b) with comorbid SAD-
(6) 
2. Adults with OCD-(12) 
3. Healthy adults-(12) 
1. ASD assessed using a 
clinically structured 
interview in line with 
DSM-IV–(Independent 
clinicians). 
2. OCD only diagnosis 
confirmed using the SCID-I 
(not specified). 
3. The SCID-I used to screen 
control group (not 
specified). 
 Groups matched for 
age, sex and educational 
level. 
 Excluded if comorbid 
severe depression, 
psychosis, mental 
deficiency or inability to 
read/speak Dutch. 
ASD symptomatology:  
 AQ (self-report). 
OCD symptomatology: 
 YBOCS (not 
specified) 
 Four questions 
measuring ego-
dystonia of 
repetitive 
symptoms (not 
specified). 
There is phenomenological 
overlap of autistic-like traits in 
comorbid ASD and pure OCD -
shared difficulties in social 
skills and attention to detail may 
reflect symptom and 
aetiological overlap. 
 
 
 
  
2
2
 
Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Ruta, 
Mugno, 
D'Arrigo, 
Vitiello, & 
Mazzone, 
2010 
1. Children with ASD-(18) 
2. Children with OCD-
(20) 
3. TD children-(22) 
1. ASD diagnosis confirmed 
using ADI-R, ADOS and 
ASD-I (not specified). 
2. OCD diagnosis confirmed 
using the K-SADS-PL (not 
specified). 
3. The K-SADS-PL used to 
screen control group (not 
specified).  
 Exclusion of individuals 
with mental retardation, 
neurological diseases, 
ADHD, tic disorder. 
 No participants 
receiving psychotropic 
medication or 
psychological therapy at 
time of study. 
 Analysis revealed no 
significant between 
group differences in 
age, gender, IQ. 
 
OCD symptomatology: 
 CY-BOCS-
(Principal 
investigator) 
 Children with OCD and 
ASD report more 
obsessions and compulsions 
than TD children. 
 Types of OC symptoms 
endorsed by the ASD vs. 
OCD group differed 
significantly  
 
Mack et al. 
2010 
1. Children with both 
OCD and ASD-(12) 
2. Children with OCD 
only-(12) 
Groups recruited from specialist 
clinic. 
1. Diagnosis of ASD in 
accordance with ICD-10 
criteria (clinical team). 
Consensus of 1 experienced 
clinician obtained.  
 
 Matched for gender and 
age. 
 IQ information not 
collected for all 
participants. 
 Children with other 
comorbidities excluded.  
 
OCD 
symptomatology:: 
 CYBOCS  
 ChOCI 
(experienced clinician). 
 
Broader difficulties: 
 SDQ-child, parent, 
teacher versions-
(Self-report). 
 
 Children with ASD may 
experience OC symptoms 
that are as impairing and 
distressing as those in 
OCD.  
 OC symptom type and 
frequency does not differ 
between groups 
significantly. 
  
2
3
 
Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Dewrang & 
Dahlgren 
Sandberg, 
2011 
1. Adolescents/young 
adults with Asperger’s 
disorder-(27) 
2. TD adolescents and 
young adults-(14) 
 
1. Previous diagnosis of ASD 
(experienced clinician). Not 
verified. 
2. The absence of 
developmental 
disorder/mental health 
difficulty not verified. 
 IQ of all participants in 
ASD group reported to 
be in ‘normal range’. 
(No evidence of 
verification) 
 Groups matched for 
age. 
OCD symptomatology: 
 The COIS-(Parents 
and young person - 
self-report). 
 The CYBOCS-
(Researcher). 
 
 No evidence of OCD 
symptomatology as 
described in DSM-IV in 
Asperger’s disorder group.  
 Some evidence of greater 
difficulties with OC 
behaviours and social 
interaction in ASD group 
from pre-school and 
throughout school. 
  
Lewin  
Wood, 
Gunderson, 
Murphy &  
Storch,  
2011 
1. Children with OCD 
only –(35) 
2. Children with both 
OCD and ASD-(35) 
1&2 – OCD Diagnosis (and 
non-ASD comorbid diagnoses) 
made using the ADIS-IV-C/P 
and confirmed by review of 
clinical records and unstructured 
clinical interview (Senior 
Clinician). 
2.  ASD diagnoses confirmed 
using ADI-R and ADOS 
(trained rater), an unstructured 
clinical interview, observation 
of child and review of records 
(Child psychologist and/or 
psychiatrist) 
 Inclusion criteria – 
OCD primary and most 
impairing diagnosis. 
 Excluded if bipolar 
disorder, psychotic 
disorder, current 
suicidality and/or IQ 
<70. 
 Matched for age and 
gender. 
 Other demographic 
variables equivalent 
between groups  
OCD Symptomatology: 
 CYBOCS-(trained 
rater) 
 OC like repetitive actions/ 
behaviours are no more 
common in individuals with 
OCD+ASD vs. those with 
pure OCD 
 There may be a 
phenotypical alteration of 
OCD in ASD.  
  
2
4
 
Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Anagnostou 
et al. 2011 
Children and young adults 
with ASD (181) 
ASD diagnosis confirmed using 
ADI-R (not specified). 
 Excluded if individual 
from family with a 
member known to have 
a medical condition 
associated with autism 
(e.g., fragile X, PKU).  
 
OCD symptomatology: 
 YBOCS – (not 
specified) 
 
 Factor analysis of YBOCS 
scores revealed 4 factor 
structure which differs from 
results of factor analyses of 
YBOCS scores in OCD 
populations  
 
Spiker, Lin, 
Van Dyke & 
Wood, 2012 
Children with HFA and a 
comorbid anxiety disorder - 
separation anxiety disorder 
(SAD), social phobia, 
generalised anxiety, or 
obsessive compulsive 
disorder (OCD) (68-specific 
group numbers not 
specified)  
 
1. ASD diagnosis 
confirmed using ADI-R, 
ADOS-module 3, parent 
report and review of 
previous assessments (not 
specified) 
2. Anxiety disorder 
confirmed using semi 
structured interview ADIS-
C/P for 84% of children. 
(Not specified). 
 
 All children had verbal 
abilities >70 on 
standardised cognitive 
assessment. 
 Children either not 
taking medication or on 
stable dose of 
medication (i.e. ≥ one 
month same dosage 
prior to assessment). 
Restrictive interests 
(RI): 
 YSIS–(parent 
report) 
 
OCD symptomatology: 
 CYBOCS –
(trained clinicians) 
 
 Children with symbolically 
enacted RIs exhibit 
significantly more 
obsessions and compulsions 
than those without these 
RIs and are related to 
obsessive hoarding, 
aggressions and 
miscellaneous obsessions.  
 Symbolically enacted RI 
may operate as a 
maladaptive coping strategy 
similar to OCD 
compulsions or these ASD-
RI behaviours and OCD 
symptoms may be confused 
due to measurement error. 
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Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Autism spectrum disorder symptoms and traits in populations with OCD 
*Zandt, 
Prior, & 
Kyrios,  
2007 
4. Children with autism-
(19) 
5. Children with OCD-
(17) 
6. TD children-(18) 
 Clinical interview with 
parents and children 
including language and 
cognitive assessments– 
(experienced professionals). 
 Excluded if comorbid 
neurological disorder, 
intellectual disability, 
language disorder 
and/or Axis 1 disorder. 
 Verbal and performance 
IQ measured (WISC-
III). 
ASD symptomatology: 
 RBQ (parental-
report) 
 
OCD symptomatology: 
 CYBOCS – 
(Clinical 
Psychologist) 
 
 Similar levels of sameness 
behaviours and repetitive 
movements in two clinical 
groups. 
 Suggests types of 
behaviours differ between 
the groups; obsessions and 
compulsions being less 
sophisticated in ASD 
group.  
 
 
*Cath, Ran, 
Smit, van-
Balkom & 
Comjis, 
2008 
4. Adults with ASD-(12) – 
(a) with comorbid 
OCD-(6) 
(b) with comorbid SAD-
(6) 
5. Adults with OCD-(12) 
6. Healthy adults-(12) 
4. ASD assessed using a 
clinically structured 
interview in line with 
DSM-IV–(Independent 
clinicians). 
5. OCD only diagnosis 
confirmed using the SCID-I 
(not specified). 
6. The SCID-I used to screen 
control group (not 
specified). 
 Groups matched for 
age, sex and educational 
level. 
 Excluded if comorbid 
severe depression, 
psychosis, mental 
deficiency or inability to 
read/speak Dutch. 
ASD symptomatology:  
 AQ (self-report). 
OCD symptomatology: 
 YBOCS (not 
specified) 
 Four questions 
measuring ego-
dystonia of 
repetitive 
symptoms (not 
specified). 
There is phenomenological 
overlap of autistic-like traits in 
comorbid ASD and pure OCD -
shared difficulties in social 
skills and attention to detail may 
reflect symptom and 
aetiological overlap. 
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Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Ivarsson & 
Melin 
(2008) 
 
Children with OCD-(109). 
OCD diagnosis confirmed by 
CYBOCS-(not specified) 
Excluded if previous 
primary diagnosis of mental 
retardation, psychotic 
disorders, anorexia nervosa 
or autism. 
 
ASD symptomatology: 
 ASSQ parental 
rating scale-(self-
report). 
Psychiatric disorders: 
 KSADS-PL 
interview-(child 
psychiatrists). 
 
 ASD traits are common in 
paediatric patients with 
OCD. 
 60% of variance of ASD 
traits in OCD not explained 
by comorbidities-suggests 
OCD itself is associated 
with some lower level ASD 
traits. 
 
 
Anholt et al. 
(2010) 
1. Adults with OCD-(109). 
2. Healthy adults-(87) 
1. OCD diagnosis confirmed 
using the SCID-I (not 
specified). 
2. The SCID-I used to screen 
control group (not 
specified).  
 Preliminary analysis 
revealed group 
discrepancy in 
education level- 
subsequently treated as 
a covariate. 
 Patients with OCD 
excluded if comorbid 
psychosis, substance 
dependence, ‘mental 
deficiency’ or unable to 
speak/read Dutch. 
 
 
 
 
ASD symptomatology: 
 AQ Danish version 
-(self-report) 
OCD symptomatology: 
 YBOCS-(self-
report) 
 
 
Substantial overlap in disorder 
symptomatology exists perhaps 
indicating overlapping 
aetiologies or shared executive 
dysfunction between disorders. 
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Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Weidle,  
Melin, 
Drotz, 
Jozefiak & 
Ivarsson  
(2012) 
1. Children with OCD-
(105) 
2. TD children-(108) 
1. OCD diagnosis confirmed 
using the KSADS-PL, 
CYBOCS and clinical 
interviews (child 
psychiatrists) and the 
CBCL (Parent self-report). 
2. ASD screened for using the 
SCQ and other psychiatric 
diagnoses screened for 
using CBCL-(Parent self-
report) 
 Group SES equivalent. 
 Matched for age and 
gender 
 Excluded from control 
group if 
neuropsychiatric 
disorder or sibling 
already taking part in 
the study. 
ASD symptomatology: 
 SCQ-(Parent self-
report) 
 
Emotional and 
behavioural problems: 
 CBCL-(Parent 
self-report) 
 
 ASD symptoms and traits 
are more common in OCD 
population than in normal 
population.  
 ASD and OCD may co 
occur in a subgroup of 
OCD population. 
 Communication difficulties 
and (less frequently) social 
difficulties are autistic 
symptoms that OCD 
paediatric patients may 
endorse. 
Autistic traits and obsessive compulsive traits within families. 
Abramson et 
al. 2005 
1. Probands with autism-
(45) 
2. Parents of probands –
(69) 
 
 
 ASD diagnosis confirmed 
using clinical evaluation, 
the ADI-R and review of 
medical records (lead 
clinicians). 
 Screening for 
neuropsychiatric disorders 
in parents not reported. 
 Probands excluded if 
developmental level < 18 
months or IQ <35, 
comorbid Tuberous 
Sclerosis complex, 
Fragile-x syndrome, 
Smith-Lemli-Opitz 
syndrome, structural brain 
abnormality and/or 
significant prenatal or 
perinatal events. 
ASD 
symptomatology: 
 ADI-R (lead 
clinician). 
 
OCD 
symptomatology: 
 Y-BOCS (self–
report version). 
 
 
There is convergence of OCD 
symptoms and insistence on 
sameness autistic repetitive 
behaviours in families.  
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Author Populations (N) Diagnostic instrument 
(delivered by) 
Group matching / Controls Measures of 
symptomatology 
(delivered by) 
Conclusion 
Kloosterman 
Summerfeldt, 
Parker & 
Holden, 2013 
1. Stage 1 - Unaffected 
parents (957), (683 
mothers; 274 fathers) 
from families with one 
or more children with 
a principal DSM-IV 
diagnosis of an ASD.  
2. Stage 2 - Unaffected 
parents (458), (298 
mothers; 160 fathers) 
from families with one 
or more children with 
a principal DSM-IV 
diagnosis of an ASD.   
Parents in stage 2 completed 
ADI-R to confirm diagnosis of 
child’s ASD - (Trained 
interviewer). 
 Comparison groups for 
stage 1 - (families with 1 
child with ASD vs. >1 
child with ASD) matched 
for gender and age. 
 
 
OCD 
symptomatology: 
 OC-TCDQ –
(Parent report). 
 
ASD 
symptomatology 
(stage 2 only): 
 
 ADI-R –(Parent 
report). 
 
 Resistance to change in 
children with ASD unique 
predictor of incompleteness 
in parents 
 Incompleteness higher in 
parents with > 1 child with 
ASD implying heritability. 
 Suggests incompleteness 
may be an endophenotype 
and underlying trait for both 
ASD and OCD. 
 
Autistic traits and obsessive compulsive traits within a healthy non-clinical population 
Wakabayashi, 
Baron-Cohen 
& Ashwin, 
2012  
1. Undergraduate 
psychology students-
(347-  
males=189:females= 
158) 
Screening of diagnostic status 
not reported. 
Order of presentation of 
measures controlled for.  
Autism 
symptomatology: 
 Japanese version 
of AQ (self-report) 
 
OCD symptomatology: 
 The PI (self-
report) 
 A small overlap of autism 
spectrum and obsessive 
compulsive spectrum may 
exist. 
 Tendency towards shared 
executive dysfunction in 
two disorders. 
 
* Studies which explored both ASD symptomatology in OCD populations and OCD symptomatology in ASD populations are included in both sections 1 and 2. 
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Table 3:  Description of measures used in research included in the review 
Instrument Version Author Measures Population Characteristics Research evidencing Reliability and 
Validity  
ASD: 
The high functioning Autism 
Spectrum Screening 
Questionnaire-(ASSQ) 
 Ehlers, 
Gillberg & 
Wing (1999) 
Symptoms characteristic of 
Asperger syndrome and other high-
functioning ASD. 
Children 
(ages: 6-17)  
Parent/ Teacher / 
Lay-informant 
report  
Ehlers et al. (1999) 
The Autism Quotient-(AQ) Original 
(English 
version) 
 
Baron-Cohen, 
Wheelwright, 
Skinner, 
Martin & 
Clubley, 
(2001) 
 
ASD traits–50 item questionnaire. 
A score of 32+ indicates likely 
clinically significant levels of 
autistic traits.  Domains covered: 
social skills, communication skills, 
imagination, attention to detail and 
attention switching.   
 
 
 
Adults 
 
 
 
Self-Report  
Baron-Cohen et al. (2001) 
Dutch 
version 
Hoekstra, Bartels, Cath, & 
Boomsma (2008) 
Japanese 
version 
Wakabayashi, Tojo, Baron-Cohen 
& Wheelwright, (2004) 
Social Communication 
Questionnaire-(SCQ) 
 Rutter, Bailey 
& Lord (2003) 
ASD symptomatology. 
Measure of symptom severity for 
both preschool and current period. 
Domains covered: social 
interaction, communication and 
repetitive/stereotyped behaviour. 
 
Children 
(ages:4+) 
Parent-report  Naglieri &Chambers (2009) 
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Instrument Version Author Measures Population Characteristics Research evidencing Reliability and 
Validity  
Autism Diagnostic Interview-
Revised-(ADI-R) 
 Lord, Rutter & 
LeCouteur, 
(1994) 
ASD symptomatology. 
Sub-sections: social interaction, 
communication/language and 
restricted and repetitive behaviours. 
Children 
(2+) to 
Adult. 
Semi-Structured 
interview- 
Clinician 
administered 
Naglieri & Chambers (2009) 
The Repetitive Behaviour 
Questionnaire-(RBQ) 
 Turner, (1995) ASD symptomatology. Severity, 
nature, frequency of repetitive 
behaviours.  Scores calculated for 
repetitive language, sameness 
behaviour, repetitive movements 
plus total repetitive behaviour. 
Children Parent/teacher 
report  
Leekam et al. (2007) 
 
Yale Special Interest Survey-
(YSIS) 
 
  
Klin, 
Danovitch, 
Merz & 
Volkmar, 
(2007)  
 
 
Restricted Interests (RI); modality 
in which they are expressed and 
measurement of the amount of time 
spent engaged in RI in different 
social domains.  
 
 
Children 
 
Parent report 
 
Klin et al. (2007)  
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Instrument Version Author Measures Population Characteristics Research evidencing Reliability and 
Validity  
OCD: 
Yale-Brown Obsessive 
Compulsive Scale-(YBOCS) 
 Goodman  
Price, 
Rasmussen & 
Mazure 
(1989); 
OCD symptom severity and 
presence 
Adults 
Clinician 
Administered 
Goodman et al. (1989) 
Steketee, Frost 
& Bogart 
(1996) 
Self-report Steketee et al. (1996) 
Children’s  Yale-Brown 
Obsessive Compulsive Scale-
(CYBOCS) 
 Scahill et al 
(1997) 
Children Clinician 
Administered 
Scahill et al. (1997) 
The Children’s Obsessive 
Compulsive Inventory-
(ChOCI) 
 Shafran et al. 
(2003) 
Obsessive-compulsive symptoms 
and associated impairment.  
Children and 
young 
people 
Self-report Shafran et al. (2003) 
Child Obsessive Compulsive 
Impact Scale-(COIS) 
 
 
 Piacentini & 
Jaffer (1999) 
Obsessive-compulsive disorder 
related impairment across settings 
e.g. school, home 
Children Self-report Piacentini, Bergman, Keller, & 
McCracken, (2003) 
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Instrument Version Author Measures Population Characteristics Research evidencing Reliability and 
Validity  
Obsessive-compulsive trait 
core dimension questionnaire-
(OC-TCDQ)  
 
 Summerfeldt, 
Kloosterman, 
Parker, 
Antony, & 
Swinson, 2001  
Obsessive-compulsive traits-two 
dimensions; harm avoidance and 
incompleteness.  
 
Adult Self-report Summerfeldt, Kloosterman, Parker, 
Antony, & Swinson, 2001  
 
Padua Inventory-(PI) Japanese 
version  
 
Sanavio, 1988 Degree of obsessive-compulsive 
traits in four main areas: 
‘contamination fears’, ‘checking’, 
‘impaired control over mental 
activities’, and ‘impulsiveness’  
Adults  Self-report Wakabayashi & Aobayashi (2007) 
OTHER: 
Strengths and Difficulties 
Questionnaire (SDQ) 
 Goodman 
(1997) 
Behavioural screening 
questionnaire: emotional and 
behavioural difficulties 
Children 
(ages: 3-16) 
Self/parent/ 
teacher report 
Goodman (2001) 
Kiddie Schedule for Affective 
disorders and Schizophrenia – 
Present and Lifetime version 
(KSADS-PL) 
 Kaufman et al. 
(1997) 
Current and past episodes of 
psychopathology 
Children Semi-structured 
diagnostic 
interview– 
Clinician 
administered 
Kaufman et al. (1997) 
Child Behaviour Checklist-
(CBCL) 
Swedish 
version 
Achenbach 
(1991); 
Larsson & 
Frisk(1999) 
Presence and extent of emotional 
and behavioural problems 
Children Parent self-report Larsson & Frisk (1999) 
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Obsessive compulsive symptoms and traits in populations with autism spectrum 
disorders 
Obsessive compulsive (OC) symptoms and traits in individuals with ASD 
were measured in ten of the sixteen studies (Anagnostou et al. 2011; Cath, Ran, Smit, 
van Balkom & Comijs, 2008; Dewrang & Dahlgren Sandberg, 2011; Lewin, Wood, 
Gunderson, Murphy & Storch, 2011; Mack et al. 2010; McDougle et al. 1995; 
Russell, Mataix-Cols, Anson & Murphy, 2005; Ruta, Mugno, D’Arrigo, Vitiello & 
Mazzone, 2010; Spiker, Lin, Van Dyke &Wood, 2012; Zandt, Prior & Kyrios, 2007).  
All ten studies used a clinician-administered version of the Yale-Brown Obsessive 
Compulsive Scale (YBOCS) (in adult populations) or CYBOCS (in child 
populations) to measure the presence of OC symptoms, the severity of these 
symptoms and the type of these symptoms endorsed.  
Four of these studies (McDougle et al. 1995; Russell et al. 2005; Ruta et al. 
2010; Zandt et al. 2007) compared symptomatology in ASD and OCD clinical 
populations. One study completed a factor analysis of YBOCS scores in an ASD 
population (Anagnostou et al. 2011).  One study (Dewrang & Dahlgren Sandberg, 
2011) compared symptomatology in those with Asperger’s disorder with healthy 
controls. One study explored the relationship between OCD traits and autistic traits 
in a population with comorbid ASD and an anxiety disorder (including OCD) (Spiker 
et al. 2012), whilst three studies (Cath et al. 2008; Lewin et al. 2011; Mack et al. 
2010) compared the symptomatology of those with OCD only with those with 
comorbid OCD and ASD (OCD+ASD).   
The earliest of these studies, completed by McDougle et al. (1995), compared 
OC symptomatology of adults with ASD with that of adults with OCD revealing 
significant differences in the types of obsessions and compulsions endorsed. 
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Specifically the ASD group were found to be less likely to experience aggressive, 
contamination, sexual, religious, symmetry or somatic obsessions and cleaning, 
checking or counting compulsions but more likely to experience repetitive ordering, 
hoarding, touching and self-damaging compulsions.  The authors concluded that the 
symptomatology of adults with OCD and adults with ASD in terms of the types of 
repetitive behaviours and thoughts experienced are different.  Groups were matched 
for age and gender and the sample size of each group was sufficient to afford 
appropriate power to detect medium group differences.  However, the validity of 
results is questionable because it is likely that the IQ of the ASD group was 
significantly lower than the OCD group, (the mean IQ in the ASD group was 69.7 
placing it in a ‘mild retardation’ range; in the OCD group, individuals with mental 
retardation or borderline intellectual functioning were excluded).  Low IQ may affect 
an individual’s ability to perceive and communicate their experiences of obsessions 
and compulsions meaning that the YBOCS may not be able to capture their true 
symptomatology.  This may explain some of the significant differences in symptom 
type found. 
This methodological limitation was addressed in Russell et al.’s (2005) study 
which again recruited adults with ASD and adults with OCD for comparison.  IQ was 
explicitly measured in the ASD group to ensure exclusion of those individuals with 
an IQ<70. Researchers also ensured each participant’s understanding of ‘obsessions’ 
and ‘compulsions’ (defined as causing some degree of discomfort or interfering with 
individual’s daily life), as distinct from repetitive behaviours characteristic of ASD, 
before administering the YBOCS.  It should be noted that making this distinction 
based on the ego-dystonia of symptoms is debatable as discussed later in the review.   
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Findings showed that obsessions and compulsions were common (50% of 
ASD group) and as distressing and time-consuming as those found in the OCD 
population. Types of obsessions and compulsions endorsed by the two groups were 
similar with the exception that somatic obsessions and checking and repeating 
compulsions were more common in the OCD group.   There are some limitations to 
this study. Comorbidities were reported to be high in the ASD group and analysis of 
the impact of this on symptomatology was not explicitly reported. The OCD group 
was significantly older than the ASD group and the authors recognised the impact 
that this discrepancy may have on the validity of the results.  Despite these 
limitations the study raises the possibility that a significant group of individuals with 
ASD may suffer from OCD symptomatology; whether this represents comorbidity 
between disorders or an overlap of core symptomatology is not clear.  
Zandt et al.’s (2007) study, which compared symptomatology in children 
with ASD, with OCD and typically developing (TD) children, measured the IQ of all 
participants and found no significant difference between groups, thus controlling for 
the key limitation of McDougle et al.’s (1995) study.  Comparison of OCD 
symptomatology revealed significantly more obsessions and compulsions in the 
OCD group than in the ASD group who in turn reported significantly more than the 
TD group.  Differences in the types of obsessions and compulsions reported by each 
group were also identified with the OCD group being more likely to endorse all 
obsessions except those of a religious theme (comparable endorsement in the ASD 
group) and miscellaneous obsessions (unspecified).  The OCD group was also more 
likely to endorse compulsions of all types except those involving another person and 
ordering compulsions where group endorsement was comparable.  Unfortunately 
these group differences are documented only as raw percentages and statistical 
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analyses have not been reported so that their significance is unclear. The authors 
concluded that the OC behaviour differs between the two groups in that it is less 
frequent and less sophisticated in the ASD group.   This conclusion is consistent with 
the results of McDougle et al.’s (1995) study. However, there were significant gender 
differences between groups with more boys in the ASD group; this may have 
impacted on the expression and type of symptomatology reported by each group and 
as such on the validity of results.  Also the existence of comorbidities in the groups 
could have been better screened for using formal diagnostic tools. 
The Ruta et al.’s (2010) study, which also compared OCD symptomatology 
in children with ASD, children with OCD and TD children, addressed the key 
methodological weaknesses of the three studies discussed. Specifically, groups were 
equivalent in age, gender and IQ and both confirmation of diagnosis and screening 
for comorbidities were completed using formal diagnostic tools. 
Consistent with Zandt et al.’s (2007) results, the authors found that the 
severity of OCD symptoms in children with OCD was significantly higher than in 
children with ASD, which in turn was significantly higher than in the TD group.  
Differences in types of obsessions and compulsions were noted.  The OCD group 
had higher levels of contamination and aggressive obsessions and checking 
compulsions. The authors noted that there were no significant differences between 
the groups’ insight into the excessiveness/senselessness of OC beliefs. They suggest 
that symptom ego-dystonia may not discriminate between the two groups.  
The authors concluded that, rather than representing comorbidity, the 
subclinical levels of OCD symptomatology in the ASD group may support the theory 
that there is a continuum of symptoms across the two disorders and an overlap 
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between them.   This study is potentially the most methodologically robust of the 
four discussed but the validity and generalisability of the results are impacted by the 
small sample size, which may have impacted the power of the analyses to detect 
differences present. 
Anagnostou et al.’s (2011) factor analysis of YBOCS scores in young people 
with ASD aimed to identify categories of obsessive and compulsive behaviours in 
autism.  The four-factor model of behaviours identified within the ASD group 
differed from models that had been derived from groups of individuals with OCD in 
previous research. Specifically, the ASD model consisted of a pure obsession factor.  
This differed from the majority of OCD models where obsessions and compulsions 
were disaggregated.  The implication is that the pattern and frequency of OC 
behaviours are substantially different between ASD and OCD groups. This is largely 
in accordance with the results of the studies discussed above.  However, these results 
are unreliable as this study did not use a well-matched OCD comparison group but 
relied on the results of previous research meaning that differences in models of OC 
behaviours could be explained by factors other than disorder, such as IQ or age.  
The findings of Dewrang and Dahlgren Sandberg’s (2011) study contradict 
the findings of previous studies discussed.  Unlike the other studies, the comparison 
of OC symptoms using the CYBOCS revealed no elevated OC symptomatology in 
the ASD group when compared to a TD group.  The results of the Child Obsessive 
Compulsive Impact Scale (COIS) demonstrated that parental and self-report ratings 
of psychosocial impairment due to OC features were significantly higher in the ASD 
group across settings.  The authors concluded that OC symptomatology is not 
experienced at a clinically significant level in the ASD group but that there may be 
sub-clinical levels of OC behaviours and related psychosocial impairment in this 
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group, which the CYBOCS was unable to identify.  However, the conclusions of this 
study are unreliable as the small sample size of the TD group (N=14) will have 
impacted the ability of the study to identify significant differences present and is 
likely to explain the inconsistent CYBOCS results.  The study does not report that 
the TD group were screened for clinical presentations and thus the absence of 
neurodevelopmental or psychiatric difficulties in this group is unconfirmed. Given 
the small sample size of this group, the impact of even a small number having a 
neuro-psychiatric condition could affect the validity of the results. 
Two studies compared OCD symptomatology in children with comorbid 
OCD and ASD with that in those with OCD only (Lewin et al. 2011; Mack et al. 
2010).  Mack et al. (2010) found no significant difference in the frequency and types 
of obsessions and compulsions between groups, except for a non-significant trend 
towards fewer somatic obsessions in the OCD+ASD group. The authors argued that 
the similarity in OC symptomatology between the two groups may point towards a 
phenomenological overlap between distressing OCD compulsions and repetitive 
behaviours characteristic of autism and that this may represent an area of genuine 
shared symptomatology.  Unfortunately IQ was not measured in all participants and 
the very small sample sizes may have resulted in the analyses being underpowered 
which could have caused the lack of difference in OCD symptoms between the two 
groups. 
Lewin et al. (2011) used well-matched groups of adequate size to power 
analyses in their study and included clinician administered measures to confirm 
diagnoses and explore symptomatology.  Similarly to Mack et al. (2010), no 
significant difference in OC symptom severity was found between the pure OCD 
group and OCD+ASD group.  However, on exploration of OC type, findings showed 
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that the OCD+ASD group were significantly less likely to experience sexual 
obsessions and/or checking, washing, cleaning or repeating compulsions than the 
pure OCD group. The authors noted that the OC behaviours in young people with 
OCD+ASD do not exclusively resemble autism-like repetitive behaviours and occur 
with equal frequency to those with OCD only.  They suggested that the reduced 
likelihood of experiencing some of the more classic OC symptoms in those with 
comorbid ASD might be explained by a phenotypical alteration of OCD in ASD, 
characterised by fewer fear-evoking obsessions. 
Cath et al. (2008) also compared the symptomatology of those with a 
diagnosis of OCD and those with a diagnosis of OCD+ASD in their study but in an 
adult population.  Consistent with Mack et al. (2010) but in contrast to Lewin et al. 
(2011), differences in symptom type between the clinical groups were not reported.  
However, in accordance with both studies, OC symptom severity in the pure OCD 
group and the OCD+ASD group was equivalent.  In contrast to Lewin et al.’s (2011) 
study, sample sizes in Cath et al.’s (2008) study were small and it is likely that 
analyses were not adequately powered to detect group differences present, which 
may explain the inconsistent results.  
Cath et al. (2008) also focussed on ego-dystonia of symptoms finding no 
between group differences. This compliments the findings of Ivarsson and Melin 
(2008) (see below) and Ruta et al. (2010) who proposed, following similar results, 
that ego-dystonia may not be an appropriate means of accurately discriminating 
between ASD and OCD symptomatology.  Cath et al. (2008) argued that previous 
research, suggesting that repetitive behaviours in ASD are more ego-syntonic, results 
from the low cognitive ability of participants and thus their inability to report 
adequately distress experienced in relation to these behaviours. 
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A fourth study (Spiker et al. 2012) investigated the relationship between 
autistic like repetitive interests (RI) (as measured by the Yale Special Interest Survey 
(YSIS)) and OCD symptoms in children with HFA and a comorbid anxiety disorder 
(which for an unspecified number was OCD). Symbolically enacted RIs (that is the 
enactment or emulation of characters or objects related to an RI) were found to be 
significantly related to more obsessions and compulsions. The authors concluded that 
either symbolically enacted RIs are a coping mechanism within ASD for OCs 
underpinned by anxiety, or that behavioural manifestations of symbolically enacted 
RIs and OCD symptoms are so alike that they are misinterpreted as each other due to 
measurement error. The lack of specificity regarding comorbid diagnosis renders 
these interpretations in relation to overlap of OC and ASD symptoms unreliable as 
the impact of specific comorbidity other than OCD on symptom presentation has not 
been accounted for.   
The conclusions of these four studies in relation to shared symptomatology of 
ASD and OCD are limited by the exclusion of a pure ASD group for comparison and 
so a lack of control for the influence of comorbidity on symptom expression in the 
two disorders. At best it is possible that these studies identify whether the 
presentation of OCD when comorbid with ASD differs significantly from the 
presentation of OCD without comorbidity.   
In summary, the results of the ten studies are variable but overall support the 
apparent existence of elevated symptoms/traits of OCD in ASD.  Four studies (Cath 
et al, 2008; Lewin et al. 2011; Mack et al. 2010; Russell et al. 2005) concluded that 
obsessive and compulsive symptoms are as common in a population with ASD and 
as impairing and distressing as in a population with OCD.  However, three of these 
four studies (Cath et al, 2008; Lewin et al. 2011; Mack et al. 2010) involved 
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comparison of OCD with comorbid OCD+ASD and as such the finding that OC 
symptom severity is comparable between groups is unsurprising.  Two studies (Ruta 
et al. 2010; Zandt et al. 2007) argued that obsessive and compulsive symptoms are 
elevated in ASD when compared to healthy controls but not as common or severe as 
those found in OCD.  However, one study (Dewrang & Dahlgren Sandberg, 2011) 
concluded that there was no evidence that OCD symptomatology, as described in the 
DSM-IV, was present in a population with ASD.  Those studies reporting on the 
differences in types of OC symptom endorsed by the two clinical groups without 
comorbidity overwhelmingly support the existence of some differences, although 
reports of where these differences lie are less consistent. Two of the three studies 
comparing OC symptomatology in OCD with that in comorbid OCD+ASD found no 
difference in types of symptom endorsed, although both studies were underpowered 
which could explain the null results.  
Autistic symptoms and traits in populations with obsessive compulsive disorder 
Autistic symptoms and traits in individuals with OCD were investigated in 
five of the sixteen studies (Anholt et al. 2010; Cath et al. 2008; Ivarsson & Melin, 
2008; Weidle, Melin, Drotz, Jozefiak & Ivarsson, 2012; Zandt et al. 2007).  The five 
studies each used different measures of ASD symptomatology and traits.  All five 
studies identified that ASD symptomatology and traits were more common in OCD 
populations than would be expected in the general population. Two studies explored 
ASD traits and symptomatology in adults with a diagnosis of OCD (Anholt et al. 
2010; Cath et al. 2008) using the Autism Quotient (AQ).   
Cath et al.’s (2008) study, which compared both ASD and OCD traits in 
adults with OCD (N=12) and adults with OCD+ASD (N=6), included only very 
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small sample sizes in each group meaning that null results need to be interpreted 
cautiously with the impact of limited power in mind. Analysis of the results of the 
AQ revealed that, although the comorbid group scored significantly higher than the 
OCD group on the AQ subscale ‘attention shifting’, the OCD group in turn scored 
significantly higher than the control group on this domain.  No significant differences 
were found between the OCD group and comorbid ASD group on AQ subscales 
‘attention to detail’ and ‘social skills’.  The authors suggested these results support 
the notion of genuine symptom overlap between the two disorders noting that, in 
addition to the repetitive behaviours characteristic of both disorders, OCD and ASD 
may also share difficulties in social skills.  In addition the authors noted that deficits 
in attention to detail reported in both groups may be underpinned by similar deficits 
in executive function.   
Correlational analyses exploring whole study group results (N=36) to 
determine any relationship between the measures used found positive correlations 
between AQ total scores and all AQ subscales (except social skills and imagination 
subscales) with the YBOCS severity scores.  The authors noted that the validity of 
these correlations, implying real relationships between separate diagnostic 
constructs, is compromised by possible measurement error; that is, where the 
measures lack specificity for their intended diagnostic constructs. 
Anholt et al. (2010) compared ASD symptomatology in adults with OCD 
with that in healthy adults. This study included large sample sizes and groups 
matched for demographic factors. The results showed that the OCD group scored 
significantly higher on the AQ than did the healthy adults, indicating elevated levels 
of ASD traits. In correlational analyses numerous relationships were found between 
ASD traits and OC symptomatology. There was an overall positive correlation 
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between AQ total scores and YBOCS severity scores. Specifically, the AQ subscales, 
attention shifting and communication, were significant predictors of OCD symptom 
severity whereas attention to detail demonstrated low correlation with OCD 
symptoms and severity.   In the prediction of specific OC symptoms the AQ 
subscales, attention switching and communication, were the most important 
predictors of OC ‘aggression and checking’, ‘symmetry and ordering’ and 
‘contamination and washing’ symptoms.  AQ scores did not predict OC hoarding 
symptoms.  Similarly to Cath et al. (2008), the authors interpreted these results as 
indicative of the substantial overlap between ASD and OCD symptomatology, which 
they suggested, may be explained by overlapping aetiologies. They also proposed 
that the importance of the AQ subscale ‘attention switching’ in predicting OC 
symptomatology may indicate shared executive dysfunction between the disorders.   
The remaining three studies in this section focussed on child populations.  Ivarsson 
and Melin (2008) explored autistic traits in a paediatric population with OCD using 
the high functioning Autism Spectrum Screening Questionnaire (ASSQ). Individuals 
with comorbid anxiety, depression, ADHD, tic disorder or ASD were included in 
order to explore the impact of these comorbidities on the expression of ASD traits in 
OCD.   The findings of this study identified significant relationships between ASD 
traits and the presence of a comorbid tic disorder, ADHD or any ASD.  These 
variables were identified as having the capacity to explain approximately 40% of the 
variance in ASD symptomatology in those with OCD. The authors purported that this 
may support the notion that a large proportion (60%) of variance in the expression of 
ASD traits in OCD cannot be explained by comorbidities and as such they suggested 
that OCD itself may be associated with some lower level ASD traits.   
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In contrast to the findings of Anholt et al. (2010), no positive relationship was 
found between ASD traits and OCD severity.  In addition, no relationship was found 
between level of insight into rationality of OCD symptoms and ASD 
symptomatology.  This brings into question the possibility that discrimination of 
OCD and ASD symptomatology can be based on symptom ego-dystonia. The 
authors concluded that the relationship between ASD traits and OCD may be 
independent of comorbidity, adding weight to the possibility that there may be a 
subsample of individuals with a diagnosis of OCD with genuine ASD traits.  
Weidle et al. (2012) explored differences in ASD traits between children with 
OCD and TD children using the Social Communication Questionnaire (SCQ), 
finding that total scores, preschool and current symptom scores were significantly 
higher in the OCD group indicating higher rates of autistic symptomatology.  
However the authors noted that not all children with OCD demonstrated ASD traits 
and therefore suggested that OCD and ASD may co-occur in only a subgroup of the 
OCD population. 
Items of the SCQ relating to preschool symptoms that were found to be 
significantly more endorsed in the OCD group included failure to use gestures and 
poor quality of social overtures.  The authors suggested that for some children with 
OCD, communication difficulties and (less frequently) social difficulties are the ASD 
symptoms most likely to be endorsed. The validity of these reported preschool 
symptoms was dependent on the accurate memory of parents. The authors noted that 
to increase the validity of results in future research a longitudinal research design 
should be employed.  
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In terms of current symptomatology significantly higher endorsement of 
verbal rituals, compulsions, hand and finger mannerisms and unusual sensory 
interests were reported in the OCD group when compared to TD children.  The 
authors acknowledged that not all SCQ items are specific to ASD and that many of 
these significant results could reflect the measures’ inability to discriminate between 
ASD specific and OCD specific symptomatology making it more difficult to draw 
conclusions.    
Comparison of group levels of emotional and behavioural problems using the 
Child Behaviour Checklist (CBCL) revealed significantly more difficulties in the 
OCD group and significantly lower total social competence scores (e.g. more likely 
to have fewer friends).   
The study also explored whether ASD traits identified in OCD can be 
explained independently of other psychiatric disorders, finding a significant 
relationship, independent of CBCL score, between group membership and SCQ 
score. However, the OCD group included a high number of participants with 
comorbid neurodevelopmental disorders (Tourette’s-16.2% and ADHD-19.2%) 
which are not necessarily accounted for by controlling for the CBCL score and may 
impact the conclusions that can be drawn in determining the independent relationship 
between ASD traits and OCD.  Other weaknesses which impact the validity of the 
findings include a lack of control for IQ differences between groups. 
In the four studies noted above it would have been beneficial to have included 
a comparison group of individuals with a diagnosis of autism such that the 
symptomatology of ASD in OCD and in ASD could have been directly compared.   
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Zandt et al. (2007) is the only study included in this section that directly 
compared ASD symptomatology in children with ASD, children with OCD and TD 
children.  The study employed the Repetitive Behaviour Questionnaire (RBQ) to 
explore ASD type repetitive behaviours in each group, finding no significant 
differences between clinical groups in total repetitive behaviour, sameness behaviour 
or repetitive movements, although both groups demonstrated significantly higher 
scores in each of these domains than did the TD group.  Repetitive language featured 
comparably at a very low level in both clinical groups but did not feature in the TD 
group.  The authors tentatively concluded that there are some similarities in 
symptomatology between the two groups in terms of levels of repetitive behaviours. 
The conclusion is rightly tentative given the small sample sizes included in this 
study, which would have impacted the ability of the analyses to detect significant 
differences between group symptomatology, if present.  
It seems all these studies imply that there are heightened levels of ASD traits 
in at least some individuals with OCD which is beyond that which can be explained 
by comorbidity alone.  Whether or not this represents genuine or superficial overlap 
in symptomatology is difficult to unpick given the apparent inability of measures 
used to identify clearly diagnostic specific constructs.   
Autistic traits and OC traits within families 
ASD and OCD symptomatology and traits within families were investigated 
in two of the sixteen studies (Abramson et al., 2005; Kloosterman et al. 2013). 
Abramson et al. (2005) explored OCD and ASD symptomatology in 45 families with 
one child with autism.  OC symptomatology in parents was measured using the 
YBOCS finding that 33% of the parents included had clinically significant scores.  
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Autistic repetitive behaviours were measured in the children with ASD using the 
restrictive and repetitive behaviour domain of the Autism Diagnostic Interview-
Revised (ADI-R) and principal component analysis revealed two main factors within 
this domain, insistence on sameness and repetitive motor and sensory phenomena.  
Correlational analysis between parental YBOCS scores and children’s autistic 
repetitive behaviours identified positive relationships between child ‘insistence on 
sameness scores’ and parental YBOCS scores.  No relationships were identified 
between the children’s overall score on the restrictive and repetitive behaviour 
domain or on the ‘repetitive motor and sensory phenomena’ subsection scores and 
the parental YBOCS scores.  The authors proposed that the results indicating 
convergence of OCD symptoms and insistence on sameness autistic repetitive 
behaviours in families might be explained by an overlap of OCD and ASD 
phenomenology, in that there may be a continuum of repetitive behaviours in autism 
which includes OC features.  Kloosterman et al. (2013), who investigated 
relationships between the OCD trait of incompleteness (using the obsessive-
compulsive trait core dimension questionnaire (OC-TCDQ)) in parents of children 
with ASD and their children’s autistic repetitive behaviours, using the ADI-R, 
revealed similar results. Specifically, resistance to change in children was found to 
be a unique predictor of sense of incompleteness in their parents.  In addition, 
repetitive sensory motor actions in the children were significantly associated with 
parental levels of incompleteness.  Sense of incompleteness was also higher in 
parents with more that one child with ASD which the authors argued implies 
heritability and suggested incompleteness may be an endophenotype and underlying 
trait for both ASD and OCD.  Unfortunately limitations in both studies limit the 
reliability of these results.  Neuropsychiatric disorders in the parent groups were not 
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screened for and so the potential impact of additional comorbidities on YBOCS/OC-
TCDQ scores cannot be ruled out.  In addition, the potential influence of parental 
modelling in determining the nature of the repetitive behaviours seen in their 
children with autism was not accounted for in either study and may offer an 
alternative explanation for the positive correlation identified between autistic 
restrictive and repetitive behaviours and YBOCS/ OC-TCDQ scores.      
Autistic traits and OC traits within a healthy non-clinical population 
One study investigated autistic and OC traits in a healthy non-clinical 
population (Wakabayashi et al. 2012). Wakabayashi et al. (2012) examined whether 
traits of OCD and ASD overlapped in a non-clinical population based on the 
analogue assumption that these clinical disorders represent the extreme end of a 
normal distribution whereby clinical symptoms differ from those found in the typical 
population only in their severity and frequency.  A large number of undergraduate 
students (N=347) were recruited resulting in appropriate power for analyses.  
Participants completed two self-report measures, the AQ (Japanese version) to 
measure ASD traits and the Padua Inventory (PI) to measure OCD traits. Moderate 
positive correlations were found between total PI and total AQ scores.  Additionally 
PI subsection ‘impaired control of mental activities’ was positively correlated with 
total AQ score whilst the other PI subsections showed weak correlations with total 
AQ score.  16% of the variance in AQ score could be explained by two PI factors, 
impaired control of mental activities and impulsiveness.  The authors compared 
individuals who scored above the AQ cut off for probable ASD diagnosis with total 
group scores on the PI, finding that the high scoring AQ group scored significantly 
higher than the total group on total PI score and on the impaired control of mental 
activities and impulsiveness subsections.  They concluded that a relationship exists 
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between traits of OCD and ASD but that this relationship is only partial, proposing 
that a partial symptom overlap may be explained by a tendency towards an executive 
dysfunction characterised by impaired control of mental activity.  They suggested 
that the differences between disorders’ symptomatology may be in part evidenced by 
the finding that repeating/checking rituals were no more common in those with high 
AQ scores, perhaps implying that these OC symptoms are not shared by or part of 
the symptomatology of those with ASD.  Although these results may add weight to 
the research in clinical populations that found some symptom overlap and argue for a 
broader phenomenological description of the disorders (e.g. Cath et al. 2008), the use 
of a non-clinical population will impact the generalisability of the results and its 
applicability and comparability to the symptomatology of those populations with 
clinically significant OCD or ASD. 
Discussion 
Main findings 
The 16 studies in this review employed a range of measures with proven 
psychometric value to explore the overlap in the symptomatology of OCD and ASD.  
Strengths of the studies as a whole included the consistent use of measures of 
symptomatology with proven psychometric value and generally high standards of 
reporting. Overall the studies provide consistent evidence for the apparent existence 
of at least sub-clinical levels of ASD symptomatology and traits in a proportion of 
those with OCD and vice versa, with variable results as to which traits and symptoms 
this applies.  
In summary, exploration of similarities and differences in OC symptom types 
endorsed by the two disorders revealed some tentative evidence that the expression 
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of OC symptoms and traits in an ASD population is largely different from that 
expressed in an OCD population.  The different studies consider where these 
differences lie, the most consistent finding being that those with OCD were more 
likely to experience checking compulsions and somatic obsessions.  Fewer studies in 
this review explored ASD symptoms in an OCD population so conclusions are 
harder to draw. However, there is some preliminary evidence for deficits in social 
skills and communication in OCD populations as well as evidence for the existence 
of autistic-like repetitive behaviours.  None of the studies found evidence for 
difficulties with language or imagination in an OCD population. 
With regard to this apparent overlap of symptomatology or traits in ASD and 
OCD, three broad explanatory models could be applied.    The first explanatory 
model is that the identified apparent elevated traits of one disorder in the other 
represent genuine symptom overlap with shared aetiology such as a common genetic 
vulnerability or neurocognitive deficit. This potential model and the possibility that 
ASD and OCD share genetic vulnerabilities is supported by research which indicates 
that the occurrence of OCD within families can predict a genetic vulnerability for 
autism (Fischer-Terworth & Probst, 2009).  For example, molecular genetic studies 
indicate a possible genetic link between OCD and ASD (e.g. Hollander et al, 1999) 
and Hollander, King, Delaney, Smith and Silverman (2003) found that repetitive 
behaviours in children with autism are frequently positively correlated with 
obsessive compulsive behaviours in parents. Additional family studies have 
implicated mutations of the serotonin transporter genes in both disorders (Fischer-
Terworth & Probst, 2009). 
In addition, research exploring neurocognitive similarities between disorders 
has revealed possible shared executive deficits, which may underpin symptoms of 
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the two disorders.  For example, Delorme et al. (2007) found the existence of 
executive dysfunction in the unaffected first-degree relatives of probands with OCD, 
which was similar to that observed in the relatives of patients with autism.  
The studies included in the current review do not provide sufficient evidence 
to support or refute this first explanatory model. However, those studies which 
investigated relationships between specific traits of the two disorders provide some 
emerging evidence for similarities, especially regarding those traits, which might be 
explained by executive dysfunction.  Specifically, measures of autistic-like 
inattention were consistently found to be positively correlated with OCD 
symptomatology.   The inclusion of studies investigating commonalities in 
neurocognitive profiles of the two disorders was beyond the scope of this review but 
these results indicate that this might be a key area for future research and could 
potentially identify more accurately any overlap in symptomatology.   
In order to support the possibility of genuine symptom overlap it would also 
be interesting to investigate the similarities and differences in symptomatology of the 
two disorders over time, employing longitudinal designs, particularly as ASD is 
considered a life-long neurodevelopmental disorder where symptomatology is 
present from a young age, which is in contrast to the current conceptualisation of 
OCD and its symptomatology.   
A second potential explanatory model is that the symptoms of ASD and OCD 
are fundamentally distinct, but that they are sometimes observed in the same 
individual due to comorbidity, where two or more discrete disorders present 
simultaneously in an individual.  Within this framework, the fact that ASD and OCD 
co-occur more often than would be expected by chance could arise because ASD is a 
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risk factor for the development of OCD and as such explains elevated traits of OCD 
in an ASD population.  It should be noted that this explanation is much less 
convincing when applied to OCD as a risk factor for the development of ASD given 
that ASD is a neurodevelopmental disorder which by definition arises in the first 
years of life.  Alternatively it could be that both disorders share a common risk factor 
making their co-occurrence more likely. 
If comorbidity were responsible for the apparent existence of elevated 
symptoms of OCD in ASD and vice versa then it would be reasonable to expect that 
this comorbidity would be identifiable by the existence of the complete range of 
symptoms of both disorders co-occurring. That is, the presentation of OCD comorbid 
to ASD should not differ substantially from OCD without comorbidity (and vice 
versa).  Two of the three studies reviewed, that compared OCD symptomatology in 
OCD+ASD with OCD without comorbidity, found no significant differences in 
symptomatology between the two groups and as such support the comorbidity 
argument.  However, both these studies were underpowered which undermines the 
validity of their null findings. In addition, the third study within this category, which 
was adequately powered, did find significant differences in symptom types between 
the two groups. 
The comorbidity argument is also insufficient when considering those studies 
that compared ASD and OCD (without comorbidity) which consistently found the 
existence of some but not all traits/symptoms of one disorder in the other and vice 
versa.  Such findings could be understood in light of the theory of ASD symptom 
fractionation (Happé, Ronald & Plomin, 2006).   This suggests that the core 
symptoms of ASD, repetitive and restrictive behaviours and social and 
communication deficits, cannot be explained by a single cause at genetic, neural or 
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cognitive level but instead that the various deficits may be explained by separate or 
‘fractioned’ causal factors (Brunsdon & Happé, 2014). The implication of this theory 
is that some elements (but not necessarily all) of ASD symptomatology may have a 
shared aetiology with symptoms seen in other disorders such as OCD.   
In addition, Ivarsson and Melin’s (2008) finding that 60% of variance in ASD 
symptomatology in those with OCD could not be explained by comorbidities 
(including ASD) undermines the adequacy of this comorbidity argument. 
Comorbidity as an explanatory model for the existence of elevated traits across 
disorders is therefore not adequately supported by the studies included in this review. 
The third explanatory model is that the disorders may not be truly related and 
the apparent overlap of symptomatology identified in the reviewed studies is in fact 
superficial and a consequence of epiphenomenon and/or measurement error. 
Epiphenomenon is where symptom(s) develop incidentally during the course of a 
disorder but are unconnected to that disorder; for example, it could be hypothesised 
that social impairments identified in some individuals with OCD are a consequence 
of core symptoms of the disorder (e.g. compulsions) rather than representing a core 
OCD symptom and an area of real symptom overlap with ASD.  Measurement error 
occurs when the measures of symptomatology employed are incorrectly identifying 
the symptom in one disorder as the same as another symptom in the other, rather than 
picking up diagnostic specific constructs.  For example, repetitive behaviours are 
reported as present in both OCD and ASD in most of the studies but convincing 
discrimination between that which is OCD-specific rather than ASD-specific has 
proven notoriously difficult (Paula-Perez, 2013). The key difficulty with making 
discriminations of symptomatology in these two clinical groups is this possibility of 
measurement error (Cath et al. 2008; Spiker et al. 2012).   
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 The ability of the studies included in this review to reach convincing 
conclusions in relation to the nature of the relationship between ASD and OCD 
symptomatology is also impacted by the lack of evidence that attempts were made to 
support participants’ and researchers’ understanding and ability to discriminate 
between OC behaviours and repetitive behaviours characteristic of autism. Where 
such discrimination has been attempted (e.g. Russell et al. 2005) it has been based on 
the premise of symptom ego-dystonia. 
Ego-dystonia of symptoms is purported by many as a means of discriminating 
between similar ASD and OCD symptomatology (Mack et al. 2010; Paula-Perez, 
2013) and in particular in relation to discriminating similar repetitive and compulsive 
behaviours, with the assumption that these symptoms would be more ego-dystonic 
and thus distressing in those with OCD.  This potentially helpful basis for 
discrimination has been addressed in three of the studies included in this review 
which specifically investigated the ego-dystonia of symptoms in the two groups, 
revealing no significant differences.  This counters the commonly held view that 
repetitive behaviours often seen in ASD are less distressing than similar repetitive 
behaviours seen in OCD and the quality and experience of these behaviours may be 
more similar than previously thought. The finding that the quality of repetitive 
behaviours in the two disorders may be more similar than previously assumed may 
support the first explanatory model that the identified apparent elevated traits of one 
disorder in the other represent genuine symptom overlap.   
Methodological issues and research implications 
The inconclusive findings of the studies included in this review highlight that 
further investigation into the overlap of symptomatology in OCD and ASD is 
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warranted to clarify the nature of the similarity of symptomatology in OCD and ASD 
and address some of the common methodological difficulties encountered by the 
research to date, allowing for more robust conclusions to be formed.    
In particular, it may be helpful for future research to include more clinician 
rated measures of symptomatology, which are based on observation of behaviours, as 
well as participant reports of symptom experience. This methodology may be better 
able to measure objectively and pick up more subtle qualitative aspects of 
symptomatology, avoid measurement error and aid ASD and OCD symptom 
discrimination.  This is particularly relevant in relation to research investigating ASD 
symptomatology in OCD.  Whilst the studies investigating OC symptomatology in 
ASD included in this review consistently employed the clinician administered 
YBOCS, all five studies investigating ASD symptomatology in OCD relied on self or 
parent report measures. It would be advisable to employ measures which are not 
reliant on self-report, such as the ADOS (Lord et al. 2000), in future research aiming 
to determine the presence and validity of autistic traits in OCD. In addition, further 
research that employs neurocognitive and genetic approaches that seek to identify 
common underpinnings for OCD and ASD symptomatology may provide greater 
insight into symptom overlap.   
Additional methodological difficulties encountered by studies included in this 
review were insufficient sample size for statistical analyses (Cath, et al. 2008; 
Dewrang & Dahlgren Sandberg, 2011; Mack et al. 2010; McDougle et al. 1995; 
Ruta, et al. 2010; Zandt et al. 2007) and/or a lack of appropriate matching of 
comparison groups (Anagnostou et al. 2011; McDougle et al. 1995; Russell et al. 
2005; Weidle et al. 2012; Zandt et al. 2007).  This inevitably will have impacted on 
the validity of the results of the affected studies as referenced throughout the body of 
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the review. Clearly future research would benefit from including comparison groups, 
carefully matched for age, gender and IQ as well as adequate sample sizes to enable 
analyses to have sufficient power to identify differences or relationships of interest.  
If the evidence-base expands in support of genuine symptom overlap between 
OCD and ASD it might be helpful to introduce research into the efficacy of 
intervention packages adapted for those individuals who experience this more shared 
presentation in symptomatology.     
Clinical implications  
The findings suggest that discrimination between the symptomatology of 
ASD and OCD is a complex task and as such more careful consideration is needed 
when making diagnoses and administering appropriate intervention packages for 
these populations.  This is particularly important given the apparent difficulty of 
many of the measures commonly employed clinically in discriminating between the 
two disorders’ symptoms and traits.  Whether such discrimination is possible is open 
to debate with previously considered distinguishing features such as symptom ego-
dystonia proving to be an unreliable dissimilarity.   
The mixed results raise the possibility that the apparent overlap of 
symptomatology may apply to a subgroup of individuals rather than to all those with 
an OCD or ASD diagnosis.  It may be that certain features (e.g. social skill deficits in 
OCD) highlight those to whom this overlap is likely to be applicable and 
identification of these features might support clinicians in the development of more 
appropriate treatment.  Clearly this is an area that warrants more research before 
conclusions can be drawn but clinician awareness of the possibility of overlap is 
important. 
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This review highlights the frequency that symptoms of repetitive behaviours 
cause distress in individuals with ASD. This has been particularly apparent in the 
studies which included individuals with a diagnosis of ASD without intellectual 
disability. These individuals were able to understand questions in relation to and 
communicate their feelings of distress.  The implication is that clinicians should take 
time to support adequately individuals with ASD, with and without intellectual 
disability, to express distress experienced in relation to their repetitive behaviour and 
should not assume symptoms are ego-syntonic.  It may be that interventions 
employed to support individuals with OCD can be adapted to support those 
individuals with ASD who experience distress in relation to repetitive behaviours. 
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Abstract  
Aims 
This study investigated whether neurocognitive performances characteristic 
of ASD co-varied with higher levels of self-reported autistic traits in adults with 
OCD in order to determine the validity of autistic traits identified.  
Method 
Twenty adults with OCD completed a measure of autistic traits (the Autism 
Quotient (AQ)) and a battery of neurocognitive assessments specifically selected to 
identify cognition associated with ASD.  Both group and multiple single case series 
designs were employed to investigate relationships between AQ scores and 
neurocognitive profiles.   
Results  
In accordance with results of previous research, adults with OCD 
demonstrated elevated levels of autistic traits on all elements of the AQ apart from 
the subscale attention to detail.  However, no clear neurocognitive profile was 
elucidated in relation to autistic traits and multiple single case series analysis did not 
clearly reveal any individuals with both autistic traits and cognition who might 
indicate the presence of an ASD subgroup within OCD.  
Conclusions  
At the group level, the results present some tenuous evidence in support of 
atypical neurodevelopment within OCD, characterised by a detail-focused processing 
style.   However, the validity of the autistic traits identified within this group is not 
supported by the results of cognitive assessments.  The exploratory multiple single 
case series analysis suggests the value of this approach in heterogeneous groups, 
such as OCD populations, in future subgrouping research.   
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Introduction 
Obsessive compulsive disorder (OCD) is a common and disabling psychiatric 
disorder characterised by obsessions (which cause marked anxiety or distress) and/or 
compulsions (which serve to neutralise distress) (American Psychiatric Association 
(APA), 2013).  The dominant conceptualisation of OCD has recently changed.  
Formerly considered a unitary nosological entity (APA, 2000) and an anxiety 
disorder, OCD is now viewed as a heterogeneous diagnostic entity where individuals 
with OCD present with disparate, non-overlapping symptom patterns.  As such, OCD 
has been reclassified under ‘Obsessive Compulsive and Related Disorders’ in the 
DSM-5 (APA, 2013) rather than as an anxiety disorder. 
Numerous ways of understanding the heterogeneous symptom presentation in 
OCD and of informing interventions have been suggested (for example, symptom 
categorisation (Rasmussen & Eissen, 1998)).  It has been proposed, for example, that 
the identification of specific abnormalities in brain anatomy, chemistry, and function 
might represent different etiologic or genetic forms of the illness and lead to the 
development of new diagnostic and treatment approaches (Rosenberg & Hanna, 
2000). 
Some OCD symptomatology bears a striking resemblance to that of the 
neurodevelopmental disorder, autistic spectrum disorder (ASD) (Bejerot, Nylander, 
& Lindstrom 2001). ASD is a lifelong disorder with an estimated prevalence of 1% 
of the population (Baird et al. 2006), characterised by impaired communication and 
social interaction, repetitive behaviours and restricted interests (APA, 2013; WHO, 
1992). Similarly many individuals with OCD are characterised by repetitive 
behaviours, ordering and symmetry compulsions (Rapoport, 1989; Rasmussen & 
Eisen, 1992). In addition, Ivarsson and WingeWestholm (2004) investigated the 
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temperamental features of children and adolescents with OCD and found that about 
half the sample had low levels of activity and sociability and high levels of shyness 
perhaps indicating impaired social interaction in some individuals similar to that seen 
in ASD.  
Bejerot et al. (2001) noted that the negative predictors of treatment outcome 
of OCD, males living alone (Buchanan, Meng & Marks, 1996), difficulties with 
interpersonal relations (Fals-Stewart & Lucente, 1993), hoarding (Black et al. 1998), 
abnormal personality, social impairment, and childlessness (de Silva, Rachman & 
Seligman, 1977), are all characteristics common in ASD.  Indeed, research indicates 
that whilst for some, OCD is episodic and remitting, for a substantial group of 
patients their illness follows a more chronic course (Venkatasubramanian, Rao & 
Behere, 2009).  This group is characterised by individuals, more often male, with 
severe symptoms and early onset OCD (Venkatasubramanian et al. 2009).  In 
addition, elevated neurological soft sign abnormalities have been identified in 
individuals with OCD (Jaafari et al. 2013) and children with OCD are more likely to 
exhibit neurological signs than adults (Geller, Biederman, Griffin, Jones & 
Lefkowitz, 1996). Familial OCD has also been found to be more prevalent in those 
with early onset OCD implicating genetic factors in this hypothesised subgroup 
(Pauls et al. 1995). Parallels between this OCD group and ASD have been drawn 
leading to the hypothesis that, at least for some individuals with OCD, a 
neurodevelopmental deviation rather than an acquired degenerative process 
contributes to the pathogenesis of the disorder (Rosenberg & Keshavan, 1998) and 
that this group may reflect those with ASD (Bejerot et al. 2001).   Furthermore, 
elevated levels of self-reported ASD traits have been identified in OCD (Anholt et al. 
2010) and levels of comorbidity between ASD and OCD are higher than would be 
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expected (25%) compared with disorder prevalence rates in the normal population 
(Russell, Mataix-Cols, Anson, & Murphy, 2005). 
The phenomenological similarities between OCD and ASD have fostered curiosity 
regarding the relationship between these disorders and some research has 
investigated similarities in symptomatology (e.g. McDougle et al. 1995; Russell et al. 
2005), biological features and genetic markers (e.g. see Jacob, Landeros-
Weisenberger and Leckman (2009) for a review). However, this research has not 
provided clear conclusions in relation to disorder overlap. It is suggested that 
investigation of the cognitive profiles of people with OCD and comparison of the 
findings with the cognitive profile commonly found in ASD might elucidate more 
clearly any shared aetiology or overlap between them.   
Cognitive neuropsychology of OCD 
Cognitive processing deficits are frequently reported and generally accepted 
to exist in OCD (Tallis, 1997), although reports of where these deficits lie are highly 
variable (Chamberlain, Blackwell, Fineberg, Robbins & Sahakian, 2005).  Theory-
based studies of neurocognitive function have yet to reveal a reliable cognitive 
profile and interpretation has often been confounded by the influence of co-
morbidities not controlled for (Chamberlain et al. 2005).  
Accordingly, the relationship between neuropsychological findings and their 
underlying brain abnormality in OCD has not been clearly elucidated (Aycicegi, 
Dinn, Harris & Erkmen, 2003; Kuelz, Hohagen, & Voderholzer, 2004; Lacerda et al. 
2003) but some neuroimaging studies have suggested that specific neural correlates 
may be associated with different symptom dimensions (Rauch & Baxter, 1998).  
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However, the finding that there is an association between OCD and 
underperformance in tasks that assess response inhibition is robust (Aycicegi et al. 
2003; Chamberlain et al. 2005; Penades et al. 2007). Chamberlain et al. (2005) 
suggest that the perseverative thoughts and behaviours that are symptomatic of the 
disorder may reflect a loss of normal inhibitory processes.  
Numerous studies investigating the neurocognitive profiles of individuals 
with OCD have identified set-shifting as a deficit (Purcell, Maruff, Kyrios & 
Pantelis, 1998; Veale, Sahakian, Owen & Marks, 1996).  Chamberlain, Robbins and 
Sahakian (2007) suggest that difficulties shifting attentional focus may result in 
cognitive inflexibility and contribute to the generation of compulsive symptoms. 
Interestingly one study found that, although individuals with OCD had poorer set-
shifting abilities than controls, those with symmetry/ordering symptoms 
demonstrated a significantly greater deficit (Lawrence et al. 2006).  
There are inconsistent results as to whether individuals with OCD 
demonstrate impairments in memory, planning and decision making abilities 
(Chamberlain et al. 2005). For example, there is a debate as to whether identified 
memory impairment in OCD represents deficits in recall or in the employment of 
appropriate organisational strategies supporting recall (Chamberlain et al. 2005).  
Similarly, there is an argument that where deficits in planning are identified, it results 
from abnormal psychomotor slowing rather than a pure planning deficit 
(Chamberlain et al. 2005). These inconsistencies have led researchers to argue that 
deficits in this area may only apply to a subgroup of individuals with OCD 
(Chamberlain et al. 2005).  In addition, mixed findings in relation to deficits in 
decision-making abilities have led researchers to hypothesise that such deficits may 
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apply only to certain forms of the disorder (e.g. treatment resistant OCD) 
(Chamberlain et al. 2005). 
Although literature does not identify social cognition impairments in OCD, 
some adults with OCD have been characterised with a behaviourally inhibited 
temperamental style, defined as a characteristic propensity to react to both social and 
nonsocial novelty with inhibition (Van Ameringen, Mancini & Oakman, 1998). This 
temperamental style has also been found to be a childhood predictor of OCD 
symptoms (Muris, Meesters & Spinder, 2003).  
The lack of consistency in neuropsychological findings does not afford any 
real certainty with regard to cognition in OCD and may reflect the heterogeneity of 
OCD and represent the existence of subtypes with distinct neurocognitive profiles 
within the disorder (Nedeljkovic et al. 2009).   
Cognitive neuropsychology of ASD 
There have been many group based studies researching cognition in 
individuals with autism, the key findings of which have implicated a number of 
common specific neurocognitive deficits and provided support for a possible shared 
pattern of cognitive strengths and weaknesses, an autistic cognitive profile (Mandy, 
Murin & Skuse, 2014).   
One of the most consistently reported findings in studies looking at cognitive 
deficits in ASD is executive dysfunction (Bennetto, Pennington & Rogers, 1996; 
Ozonoff & Jensen, 1999; Pennington & Ozonoff, 1996; Prior & Hoffman, 1990; 
Rumsey & Hamburger, 1988; Russell, 1997). Executive dysfunction refers to deficits 
in those skills required to prepare for and execute complex behaviour (Ozonoff et al. 
2004).  Deficits and differences in executive function in those with autism have been 
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implicated particularly in the non-social aspects of ASD such as repetitive and 
stereotyped behaviours (Pennington & Ozonoff, 1996). 
Within the construct of executive function is a relatively robust finding that 
set-shifting is impaired relative to age and IQ matched typically developing controls 
(Ozonoff et al. 2004; Pennington & Ozonoff, 1996).  In addition, in ASD the 
repetition of certain behavioural patterns may result from an inability to generate 
novel behavioural patterns.  Generativity is a process which requires respondents to 
generate spontaneously appropriate novel responses. Impaired generativity is thought 
to mediate deficits in pretend play commonly identified in children with ASD 
(Turner, 1997).   Inhibition, when strictly defined (that is, teased apart from tasks 
demanding cognitive flexibility), appears to be intact among persons with autism 
with developmental levels greater than 6 years (Russo et al. 2007).   
In addition to the executive dysfunction theory in autism are two other 
prominent theories which are proposed to explain differences in cognition and which 
might underpin behavioural aspects of ASD.    
Impairments in theory of mind (TOM), that is the ability to mentalise or to 
identify and attribute mental states to others (Leslie, 1987), have been consistently 
demonstrated in those with autism and are theorised to underpin the difficulties in 
social functioning and communication which are defining features of autism (APA, 
2000; Baron-Cohen & Wheelwright, 2003; Orsmond, Krauss & Seltzer, 2004).   
Weak central coherence in autism is also frequently observed, that is 
individuals with ASD have a more detailed focussed style of processing and are thus 
less likely to integrate local information in the search for global meaning (Frith & 
Happé, 1994). Weak central coherence has been implicated in commonly identified 
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ASD characteristics such as insistence for sameness/routine and attention to parts of 
objects (Booth & Happé, 2010).   
The theories and research outlined above provide information to define a 
possible disorder-specific cognitive profile for autism which is characterised by 
impairments in set-shifting, generativity and theory of mind but strengths in detail-
focussed processing and inhibition (Mandy, Murin & Skuse, 2014).   
Comparison of cognitive profiles of OCD and ASD  
There is currently a paucity of research into the similarities and differences in 
the cognitive profiles of ASD and OCD. To our knowledge two studies (Delorme et 
al. 2007; Zandt, Prior & Kyrios, 2009) have attempted to compare the neurocognitive 
profiles of the two groups but clear conclusions have not been reached. Zandt et al. 
(2009) found that areas of cognitive impairment differed between the two disorders; 
specifically children with ASD showed deficits in generativity whilst those with 
OCD demonstrated deficits in inhibition.  Zandt et al. (2009) concluded that 
similarities in symptoms of the disorders (specifically repetitive behaviours) might 
be superficial and derived from different cognitive processes.  In contrast, Delorme 
et al. (2007) proposed that shared cognitive deficits, specifically in planning and 
spatial working memory, do exist, potentially representing a shared cognitive 
phenotype, which explains similar symptomatology of the two disorders.  However 
the potential impact of anxiety on cognitive processes is highlighted as a 
confounding factor which may affect the reliability of these results.  
To our knowledge no study has investigated the neurocognitive profiles 
within a population of adults with OCD in relation to their levels of autistic traits.  If 
high levels of autistic traits are found to co-occur with an autistic cognitive 
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performance it would support the validity of autistic traits identified within an OCD 
population.   
In addition, to date, the majority of studies investigating cognitive abilities in 
OCD have been designed to accommodate statistical comparison of group means.  
There is a risk that relying solely on this group methodology may preclude analysis 
of the heterogeneity evident in the cognitive abilities of individuals with OCD and 
obscure identification of the existence of groups of individuals within OCD with 
distinct patterns of cognitive deficits (Towgood, Meuwese, Gilbert, Turner & 
Burgess, 2009).  As such, in addition to group analyses, a statistical approach (novel 
in its application to OCD), multiple single case series methodology, will be applied 
in this exploratory study using a broad range of neuropsychological assessments to 
explore the patterns of cognitive strengths and difficulties of individuals with OCD.   
Aims and hypotheses of study 
The study has three key aims: 
1. To replicate previous findings of elevated levels of self-reported autistic traits 
in a population of individuals with OCD. 
2. To investigate whether levels of autistic traits co-vary with elements of 
cognitive performance that are associated with ASD.  Specifically, it is 
hypothesised that impairment in cognitive deficits common to ASD, set-
shifting, theory of mind, and generativity and weak central coherence, will be 
positively correlated to levels of self-reported autistic traits whilst no such 
relationship is predicted between inhibition and self-reported autistic traits.   
3. To investigate, using a multiple single case series approach, whether there are 
individuals with OCD who demonstrate both elevated self-reported autistic 
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traits and cognitive profiles associated with ASD.  Specifically, we wanted to 
explore the possibility that these autistic traits and cognition are limited to a 
subgroup of individuals with OCD.    
 
Method 
Setting 
The study took place at an NHS clinic specialising in OCD services.  
Participants 
 Sample size 
 Intended power 
A power analysis for this study was carried out using G-Power (Faul, 
Erdfelder, Lang & Buchner, 2007) to estimate an appropriate sample size. No 
comparable single samples group comparison studies or correlational studies were 
identified and, as such, necessary sample size to achieve adequate power for these 
analyses was based on an assumption of a medium effect size of d=0.5 (for the group 
comparisons) and r=0.3 (for the correlational analyses).   Therefore, for both single 
samples group comparisons and correlational analyses, sample size was calculated 
based on an effect size of d=0.5 or r=0.3 respectively, an alpha setting at 0.05 and a 
power of 0.8.  These calculations determined that sample sizes of N=34 and N=82 
were necessary to achieve adequate power for the single samples group comparisons 
and correlational analyses respectively.  Unfortunately, difficulties with recruitment 
in the current study (see participant recruitment) meant that reaching the desired 
sample size to achieve adequate power for group comparisons and correlational 
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analyses was not possible and caution will therefore be exercised in interpreting 
results. 
 Achieved power 
A power analysis was also completed for this study using G-Power (Faul, et 
al. 2007) to determine the effect size that the actual sample was powered to detect. 
Based on actual sample size achieved (N=20) with alpha setting at 0.05 and a power 
of 0.8, the sample provided sufficient power to detect large effect size, greater or 
equal to r=0.55, for the correlational analyses and large effect size, greater or equal to 
d=0.66, for the group comparisons. 
 Demographics 
Participants were 20 outpatients with a current diagnosis of OCD at the NHS 
OCD clinic where the research was being conducted. Participants were 14 females 
and 6 males with a mean age of 46.35 years (SD = 11.26). They were recruited 
following their participation in a pilot study taking place at the OCD services to 
determine levels of self-reported autistic traits (see procedure for detail).  Participants 
were eligible if they were over 18 and spoke fluent English and excluded if they had 
current or history of head trauma or neurological impairment or learning disability.  
All participants who had completed participation in the pilot study and provided 
consent to be contacted regarding future research met inclusion criteria for the 
current study.  Table 1 summarises the participant characteristics. 
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Table 1: Demographic characteristics of study sample 
 
Participant characteristic Number Percent a Mean SD Range 
Gender: 
             Male 
             Female 
 
 
6 
14 
 
30 
70 
   
Age 
 
  46.35 11.26 26-62 
Marital Status: 
             Single 
             Married 
             Divorced 
             Widowed 
 
 
9 
8 
3 
0 
 
45 
40 
15 
0 
   
Employment status: 
             Employed 
             Unemployed 
             On sick leave 
             Retired   
 
 
7 
9 
1 
2 
 
36.84 
47.37 
5.26 
10.53 
   
IQ (WASI FSIQ) 
 
  89 9.22 75-111 
Comorbidity 
  Affective disorder  
  Psychotic disorder 
  Neurotic disorder 
  Addictions 
  Personality disorder 
  Other psychological disorder 
  Physical disorder 
 
 
10 
1 
0 
1 
3 
5 
6 
 
50 
5 
0 
5 
15 
25 
30 
   
Note. a: The percentage values given are calculated on the basis of the number of 
respondents who provided information on the respective demographic variable 
Abbreviations = WASI FSIQ, Wechsler Abbreviated Scale of Intelligence ®, Full Scale IQ 
(Wechsler, 1999). 
 
A one samples t-test revealed that the mean IQ of the current population was 
significantly lower than the mean normative score (M=100, SD=15) published for 
the WASI –II (Wechsler, 1999); t(19)=-5.34, p<0.001.    As such the impact of 
current sample IQ on analyses completed will be considered as appropriate. 
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Procedure 
This study formed part of an on-going larger investigation currently being 
conducted at the NHS OCD clinic where this research was being completed.  Adults 
with a primary diagnosis of OCD were invited to enrol in a cross-sectional study to 
investigate the prevalence of autistic disorder and traits in the OCD population.  
Participants recruited were screened for the presence of autistic symptoms using the 
Autism Quotient (AQ) (Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 
2001).  
In addition all individuals referred to this service are assessed for OCD 
severity using the Yale-Brown Obsessive Compulsive Scale (YBOCS) (Goodman, 
Price, Rasmussen & Mazure, 1989) administered by a clinician.  The current 
diagnosis of OCD in participants recruited to the study was confirmed where 
possible through repetition of a YBOCS administered by a clinician.  
All participants taking part in this larger investigation, who consented to be 
contacted regarding further research, were identified for inclusion in the current 
study.  Following identification of suitability, these individuals were contacted to 
determine interest in participation and where appropriate recruited to the study.   
Participants were recruited jointly with Josselyn Hellriegel (trainee clinical 
psychologist), with whom I jointly tested the participants for our studies (Hellriegel, 
2014). For the purposes of this paper and for clarity, I will only explain the methods 
for my study but please see Appendix 2 for details of joint work. Each testing session 
involved the completion of mood screens and a series of neuropsychological tests 
(see measures), lasted approximately 3 hours and took place at an NHS hospital in a 
standard clinical room. Breaks were provided when appropriate and required.  At the 
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end of the testing session participants were reimbursed travel expenses (up to a 
maximum of £10), debriefed and any questions were answered.  
Participant recruitment  
At the time of recruitment for the current study 92 participants had been or 
were due to be enrolled in the pilot study. Of these, 37 had not completed the pilot 
study and were therefore ineligible for the current study and one participant had not 
provided consent to be contacted regarding future research.   The remaining 54 
participants were sent a participation information sheet (PIS) (see Appendix 1) in the 
post by the researchers which outlined the purpose of the study and what would 
happen should they choose to become involved.  Allowing for 48 hours post-receipt 
of the PIS, we attempted to contact all 54 participants by phone to discuss their 
participation in the current study.  We were unable to reach 16 participants by phone; 
either the phone number available was incorrect or the individual did not pick up, 
despite numerous attempts and messages left with contact numbers for returning 
calls.  Eleven participants did not want to take part in more research and one 
participant was interested in the research but felt too unwell to partake at that time. 
Twenty-six participants agreed to take part in the study and were booked into 
appointments, of whom five cancelled their appointments due to ill health and one 
did not attend their appointment, leaving 20 participants who completed the study.  A 
diagram of the recruitment process can be seen in Figure 1. 
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Figure 1: Participant recruitment 
 
 
 
 
 
 
 
 
 
Ethical Considerations 
 
 
 
 
 
 
 
 
Participants involved in 
pilot study at time of 
recruitment (N=92). 
Sent participation 
information sheet (PIS)   
(N=54) 
Participants agreed to take 
part and appointments 
booked (N=26) 
 
Attrition (N=28) 
-Contact number incorrect 
or no answer on contact 
numbers available (N=16) 
-Did not want to take part 
in current study (N=11) 
-Felt too unwell to take 
part (N=1) 
Excluded (N=38): 
-Incomplete data sets 
from pilot study 
(N=37). 
-Consent to be 
contacted regarding 
future research not 
granted (N=1) 
 
Contact attempted by 
telephone - 48 hours post 
receipt of PIS (N=54) 
Completed Study (N=20) 
 
Attrition (N=6): 
-Appointment cancelled by 
participant due to ill health 
(N=5) 
-Appointment DNA (N=1) 
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Ethical approval 
Ethical approval was obtained from the Harrow NHS ethics committee (See 
Appendix 3).  All participants were provided with a detailed information sheet 
emphasising that their non-participation would not affect the care they receive.  
Written consent was attained from all participants (See Appendix 4).  All information 
collected remained confidential and was held anonymously. 
Measures 
During the testing session participants completed a range of valid and reliable 
neuropsychological tests to assess a wide range of cognitive abilities (outlined below; 
see Appendix 5 for detailed descriptions of tests).  These tests are routinely used in 
UK clinical neuropsychological practice and were administered according to the 
procedures outlined in the appropriate testing manuals or published papers.  A fixed 
order of testing was used for all participants. 
Intelligence. Intelligence was measured using the 2 subtest version of the 
Wechsler Abbreviated Scale of Intelligence ® (WASI – II) (Wechsler, 1999).  
 
Overall executive function.  Overall executive function was measured using the 
modified six elements subtest of the Behavioural Assessment of the Dysexecutive 
Syndrome (Wilson, Alderman, Burgess, Emslie & Evans, 1996). 
 
Set-shifting.  Set-shifting (cognitive flexibility) was measured using the intra-
extra dimensional (IED) shift task from the Cambridge Automated 
Neuropsychological Test Battery (CANTAB) (Cambridge Cognition, 2006). 
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The CANTAB is a computerised neuropsychological touch-screen test battery 
which incorporates a number of executive and memory tasks examining a range of 
neurocognitive functions which tap the frontal lobes and their sub cortical 
connections (Patel et al. 2010).  
Response inhibition. Response inhibition was measured using the Stop Signal 
task from the CANTAB (Cambridge Cognition, 2006).  
 
Generativity.  Generativity was measured using the design fluency subtest from 
the Delis-Kaplan Executive Function System (D-KEFS) (Delis, Kaplan & Kramer, 
2001).  
 
Theory of mind (TOM). Theory of mind was measured using the Revised Eyes 
test (Baron-Cohen, Wheelwright, Hill, Raste & Plumb, 2001).  
 
Central coherence. Central coherence was measured using the Rey-Osterrieth 
Complex Figure Test (RCFT) (Osterrieth, 1944).  
 
In addition levels of participant anxiety and depression were assessed using the 
following measures (See Appendix 5 for details of these measures): 
 
Anxiety.  The State-Trait Anxiety Inventory (STAI) (Spielberger, Gorsuch & 
Lushene, 1970).   
 
Depression.  The Montgomery-Asberg Depression Rating Scale (MADRS) 
(Montgomery & Asberg, 1979).  
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Before participation in the current study participants completed the following 
measures of clinical symptomatology as part of the larger investigation being 
conducted at the NHS clinic (as described above): 
Autistic traits. The Autism Quotient (AQ) (Baron-Cohen et al. 2001) was 
used to screen for autistic traits. The AQ is a 50 item questionnaire designed to 
quantify autistic traits in individuals with normal intelligence.  Each question 
demands a forced choice response on a four point Likert scale which allows the 
participant to indicate the extent to which they agree or disagree with the item. The 
questions are equally divided to cover five different domains associated with ASD: 
social skills; communication skills; imagination; attention to detail; and attention 
switching.  
The total AQ score (which can range from 0-50) has been used to screen for 
individuals with likely ASD.  A score of 32+ on the AQ has been proposed as a 
useful cut off for distinguishing those who have clinically significant levels of 
autistic traits (Baron-Cohen et al. 2001), and correctly identifies 76% of patients 
(sensitivity 0.77, specificity 0.74) when the AQ is used in a referred clinical sample 
(Ruzich et al. 2015).  Alternatively a score of 26+ on the AQ has been proposed as a 
more useful cut off threshold (sensitivity is 0.95, specificity 0.52, positive predictive 
value 0.84, and negative predictive value 0.78) as it correctly classifies a greater 
number of individuals, 83% (Woodbury-Smith, Robinson, Wheelwright & Baron-
Cohen, 2005).  The AQ has demonstrated good psychometric properties (Baron-
Cohen et al. 2001); the total AQ score and its five subscale scores are normally 
distributed, have demonstrated good test-retest reliability and good internal 
consistency (Ruzich et al. 2015).   
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OCD symptom severity.  OCD symptom severity was measured using the 
Yale-Brown Obsessive Compulsive Scale (YBOCS) administered by a clinician.  
The YBOCS is widely acknowledged as the gold standard measure of OCD 
symptom severity and presence; it is a clinician-administered instrument with good 
psychometric properties (Goodman, Price, Rasmussen & Mazure, 1989). 
Design 
Both group and multiple single case series designs were employed to 
investigate relationships between the AQ scores of individuals with OCD and their 
neurocognitive profiles.   
Statistical analysis 
Data was analysed using SPSS 22.0 for windows.  All data was explored for 
assumptions of normality. Where assumptions were not met, an appropriate non-
parametric test was used as appropriate.  There were no outliers or data excluded.  
All statistical tests used a 0.05 significance level. 
One sample T-tests were completed to compare sample population mean 
scores on neurocognitive tasks to normative means for each task. 
Within group correlational analyses between AQ scores and scores on 
neurocognitive tasks were completed. 
Multiple single case series methodology was employed to analyse individual 
participant cognitive profiles.  In multiple single case series design, differences 
within, rather than between individuals are the basis of investigation and each 
individual acts as their own control (Towgood et al. 2009).  This approach is 
considered particularly useful when the heterogeneity of a condition, such as OCD, 
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may lead to group means, which may not reflect the behaviour of any individual 
within that group (Shallice, Burgess & Frith, 1991).  
Results 
 
Sample characteristics 
Mental health of participants 
 
Table 2a and 2b show the clinical characteristics of the study sample. 
 
Table 2a: Characteristics of OCD within study sample 
 
Participant characteristic Number Percent  Mean SD Range 
OCD severity* 
          YBOCS compulsions 
          YBOCS obsessions 
          YBOCS Total 
 
 
18 
18 
18 
 
 
90 
90 
90 
 
 
10.53 
10.24 
19.94 
 
4.33 
3.51 
7.77 
 
2-18 
3-17 
6-35 
OCD – age of onset 
 
  11.70 5.66 5-25 
OCD – Treatment stage** 
             Stage 1 
             Stage 2 
             Stage 3 
             Stage 4 
             Stage 5 
             Stage 6 
             Stage 7 
 
 
0 
2 
4 
3 
2 
6 
3 
 
0 
10 
20 
15 
10 
30 
15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note.  
*Of the total sample (N=20), YBOCS data was missing for 10% (N=2).  
**See Appendix 6 for definition of treatment stages. 
 
Of the total sample, 90% (N=18) had completed the YBOCS at the start of 
the study.  Of these, 16 participants had clinical levels of OCD symptoms 
(considered to be indicated by a score >7 (Goodman et al. 1989)); 11.11% (N=2) had 
subclinical levels of OCD symptoms (scoring between 0-7); 16.67% (N=3) had mild 
symptoms of OCD (scoring between 8-15); 33.33% (N=6) had moderate symptoms 
of OCD (scoring between 16-23); 33.33% (N=6) had severe symptoms of OCD 
(scoring between 24-31); and 5.56% (N=1) had extreme symptoms of OCD (scoring 
between 32-40).  
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Table 2b: Levels of depression and anxiety within study sample 
 
Participant characteristic Sample Mean (SD) Range 
 
MADRS score 
(Depression) 
17.80 (8.03) 7-32 
STAI–Trait Score (Trait 
anxiety) 
59.25 (6.77) 44-67 
STAI–State Score (State 
anxiety) 
43.10 (13.55) 21-80 
 
Symptoms of depression: 
100% of the participants had elevated symptoms of depression (considered to 
be indicated by a score >6 on the MADRS (Herrmann, Black, Lawrence, Szekely & 
Szalai, 1998); 70% (N=14) had mild symptoms of depression (scoring between 7-19) 
and 30% (N=6) had moderate symptoms of depression (scoring between 20-34).   
Self-reported Symptoms of anxiety: 
100% of the sample (N=20) completed the STAI.   Of these, 50% (N=10) had 
clinically significant levels of anxiety (considered to be indicated by a score above 
39-40 on the STAI-State inventory (Addolorato et al. 1999; Knight, Waal-Manning 
& Spears, 1983).   
In addition normative means for the scores on both the STAI Trait and State 
in adults divided according to gender are, for men, a mean STAI-State score of 35.72 
(SD= 10.40) and mean STAI-Trait score of 34.89 (SD=9.19); for women, a mean 
STAI-State score of 35.20 (SD= 10.61) and a mean STAI-Trait score of 34.79 (SD= 
9.22) (Spielberger et al. 1970). Calculating comparative normative means for the 
current sample according to gender ratio yielded a STAI-State mean score of 34.82 
(SD=9.21) and a STAI-Trait mean score of 35.36 (SDS =10.55).  Using these 
proposed normative means for the STAI inventory in one samples t-tests revealed 
significantly higher STAI State and Trait scores in the current sample compared to 
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the normative sample (t(19) =2.73, p=0.013; t(19)=15.77, p<0.001 respectively).  
This suggests that the current sample expressed significantly more symptoms of trait 
and state anxiety than the normative population. 
Medication: 
All participants (N=20) were taking at least one form of medication for 
mental health difficulties at the time of the study.  90% (N=18) were taking a 
selective serotonin re-uptake inhibitor (SSRI), 5% (N=1) were taking tricyclic 
antidepressants (TCAs), 50% (N=10) were taking an antipsychotic medication and 
15% (N=3) were taking an anxiolytic medication.  
Levels of self-reported autistic traits in the study sample 
Table 3: Levels of autistic traits within study sample vs. normative sample: AQ total 
and subscale scores 
 
Measure of Autistic Traits Mean (SD) current 
sample (N=20)  
Range Mean (SD) Baron-Cohen 
et al.(2001) norms (N=174) 
 
AQ Total 
 
25 (6.93) 
 
10-36 
 
16.40 (6.30) 
 
AQ Subscales: 
        Social Skills 
        Attention Switching 
        Attention to detail 
        Communication 
        Imagination 
 
 
4.60 (2.39) 
7.50 (1.82) 
5.15 (2.23) 
4.05 (1.85) 
3.70 (2.58) 
 
 
1-9 
3-10 
1-9 
0-7 
0-8 
 
 
2.60 (2.30) 
3.90 (1.90) 
5.30 (5.20) 
2.40 (1.90) 
2.30 (1.70) 
 
All participants included in this study (N=20) completed the AQ, of which 
15% (N=3) scored 32 or above and 40% (N=8) scored 26 or above, both potentially 
indicating clinically significant levels of autistic traits.  Baron-Cohen et al. (2001) 
suggest that only 8% of the general population would score 26+ on the AQ; 
comparative analysis indicates that the occurrence of clinically significant levels of 
self-reported autistic traits within the current population (40%) is significantly 
greater than that which would be anticipated in the general population (p<0.001). 
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A one-sample t-test revealed that the mean total AQ score in the current 
sample was significantly higher than the mean total AQ score of the normative 
sample in Baron-Cohen and colleague’s (2001) study; t(19)= 5.55, p<0.001.   
In addition, one sample t-tests revealed significantly elevated scores (at 
p<0.05) in the current population on all AQ subscales when compared to the 
normative sample, apart from the AQ subscale attention to detail where there was no 
significant difference between the normative and current sample mean scores. 
Relationships between measures of clinical symptomatology 
Correlational analyses between scores on the AQ, MADRS and STAI 
revealed a number of significant relationships.  The total score on the AQ was found 
to be significantly positively correlated to scores on both the MADRS and STAI-
Trait Inventory (r(18)=0.62, p=0.004 and r(18)=0.51, p=0.023 respectively).  The 
impact of mood will therefore be considered in the analysis of any relationship 
between AQ score and performance on neurocognitive task.  
There were also significant positive correlations between the scores on both 
the Trait and State Inventories on the STAI and the scores on the MADRS 
(r(18)=0.58, p=0.007 and r(18)=0.48, p=0.032 respectively).  The common co-
occurrence of anxiety and depression is widely acknowledged (Lamers et al. 2011) 
and as such this relationship is not unexpected. 
No significant relationships were found between current OCD 
symptomatology as measured by the YBOCS and levels of autistic traits measured 
by the AQ indicating that levels of autistic traits are independent of the current level 
of OCD symptomatology and vice versa.  
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Neurocognitive performance of participants 
In order to explore the performance of the current clinical sample on each 
neurocognitive task, their scores were compared, where available, to widely 
published normative scores using one samples t-tests. As data obtained from the stop 
signal task was significantly skewed and as such not normally distributed, a non-
parametric equivalent, the one sample Wilcoxon signed rank test, was used to 
compare the normative and sample performance on the inhibition task. 
Table 4: Mean scores attained on each neurocognitive measure: study sample vs. 
normative sample.  
 
Neuro-
cognitive 
domain 
Neurocognitive 
task 
Clinical sample 
Mean, (SD), range 
aNormative 
Mean, (SD) 
Comparison of sample 
means and normative 
means 
Central 
Coherence 
ROCF- 
Immediate recall 
Delayed recall 
 
 
37.75, (15.99), 20-69 
37.45, (17.08), 20-70 
 
50 (10) 
50 (10) 
 
t(19)=-3.43, p=0.003** 
t(19)=-3.29, p=0.004** 
Generativitiy DKEFS- 
Total Correct 
Composite score 
Contrast score 
 
 
9.10, (2.67), 5-15 
9.15, (2.46), 6-15 
9.25, (2.83), 3-15 
 
10 (3) 
10 (3) 
10 (3) 
 
t(19)=-1.51, p=0.15 
t(19)=-1.55, p=0.14 
t(19)=-1.19, p=0.25 
Inhibition CANTAB – SST 
SSRT 
 
173.62, (74.19), 
87.23-407.35 
186.50 
(41.14) 
 
Z = 67, p=0.16 
Set-Shifting CANTAB – IED 
Total errors (adj) 
EDS errors 
Stages completed 
 
32.25, (24.21), 7-75 
13.85, (11.81), 2-30 
8.30, (0.98), 7-9 
 
24.15(26.82) 
7.52 (8.27) 
8.62 (1.07) 
 
 
t(19)=1.50, p=0.15 
t(19)=2.40, p=0.03* 
t(19)=-1.47, p=0.16 
Theory of 
Mind 
 
Mind in the Eyes- 
Revised 
 
25.95, (4.07), 20-33 
 
26.20 (3.6) 
 
t(19)=-0.28, p=0.79 
 
General 
Executive 
Function 
BADS- 
Six Elements 
Task 
 
3.65, (0.49), 3-4 
 
3.52 (0.8) 
 
t(19)=1.19, p=0.25 
 
Note. *Indicates p<0.05. **Indicates p<0.01. 
 
a See Appendix 7 for source of normative data. 
Abbreviations = BADS: Behavioural Assessment of Dysexecutive syndrome (Wilson et al. 1996). 
DKEFS: Delis-Kaplan Executive Function System (Delis, et al. 2001). ROCF: Rey-Osterrieth 
Complex Figure Test (Meyers & Meyers, 1995). IED: Intra-Extra Dimensional Task, EDS: Extra-
Dimensional Shift (Cambridge Cognition, 2006). SST: Stop Signal Task, SSRT: Stop Signal Reaction 
Time (Cambridge Cognition, 2006). 
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Compared to the normative population, one sample t-tests revealed that the 
current population displayed significantly greater detailed-focussed processing in 
tasks of central coherence (p<0.01) and possible impairment in set-shifting at the 
point of extra dimensional shift (represented by the EDS error scores) (p<0.05).  
Significant impairments were not identified in generativity, TOM, inhibition or 
overall executive function compared to the normative populations.  It should be 
noted that performance on the BADS modified six elements task, which measures 
general executive function, seemed to be at ceiling for the current clinical population 
and similar ceiling effects for this task have been noted within the normative 
population (Strauss, Sherman & Spreen, 2006) 
Relationship between AQ scores and neurocognitive performance 
It was hypothesised that neurocognitive performance would be associated 
with autistic traits; specifically it was hypothesised that a higher AQ score, indicating 
greater levels of autistic traits, would be significantly associated with greater 
impairments in overall executive function, set-shifting, TOM and generativity and 
weaker central coherence. In addition it was hypothesised that AQ score and greater 
levels of autistic traits would be negatively correlated to impairments in inhibition. 
 Control strategy 
In order to ensure the reliability and validity of any relationships found 
between the variables of interest in this study, it is necessary to control for the 
presence of any other variable (or confound) that may, through association with the 
variables of interest, distort the outcome and lead to inaccurate results.    
Given the low power of the study, in order to determine whether to control 
for IQ as a third variable, not only significant relationships but also trends (referring 
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to those associations with an alpha value, p<0.1) were considered sufficient to justify 
inclusion as a control variable (see correlation matrices in Appendix 8 and 9). There 
were no significant relationships identified between IQ and performance on any of 
the neurocognitive tasks apart from significant positive correlations between IQ and 
performance on the tasks of central coherence (ROCF-delayed and immediate recall) 
and the total number of correct responses achieved on the generativity task 
(DKEFS); (r(18)=0.51, p=0.02, r(18)= 0.56, p=0.01 and r(18)=0.45, p=0.05 
respectively).   Trends (p<0.1) were also identified between IQ and performance on 
the composite score in the generativity task (DKEFS), the set-shifting outcome 
measures, IED total errors adjusted and stages completed, and performance on the 
task of TOM (Mind in Eyes).  A significant relationship was also identified between 
IQ and the AQ subscale attention shifting (r(18)=-0.46, p=0.04). As such, when 
investigating the relationship between the autistic trait ‘attention shifting’ and 
performance on these seven neurocognitive tasks, IQ was entered into the analysis to 
control for its effect on performance.    
In addition, given the significant relationships between AQ score and STAI-
Trait and MADRS scores, a preliminary correlational analysis was also performed to 
determine whether relationships between scores on the STAI-Trait and MADRS and 
neurocognitive performance might exist independently of AQ.  Given the low power 
of the study, in order to determine whether to control for mood as a third variable, 
not only significant relationships but also trends (referring to those associations with 
an alpha value, p<0.1) were considered sufficient to justify inclusion as a control 
variable. (see correlation matrices in Appendix 8 and 9). Statistically significant 
relationships and trends were found between the AQ total and all AQ subscales 
scores (apart from ‘attention to detail’) and MADRS scores.  No statistically 
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significant relationships were found between these mood measures and 
neurocognitive performance. However trends (p<0.1) were identified between 
performance on the set-shifting tasks (IED total errors (adjusted) and Stages 
completed) and levels of depression.  Thus, in investigating the relationship between 
autistic traits in all domains (apart from attention to detail) and performance on these 
neurocognitive tasks, the MADRS scores were entered into the analysis as a 
confounding factor to control for its effect on performance.  Neither significant 
relationships nor trends were identified between STAI- Trait scores and any of the 
neurocognitive scores and no significant relationships or trends were identified 
between STAI-State and neurocognitive scores.  Therefore, it is assumed that levels 
of anxiety are not confounding factors in the relationship between autistic traits and 
neurocognitive performance.    
Correlational analyses – AQ scores and neurocognitive performance 
Pearson’s correlational analyses were performed to assess the strength of 
relationship between AQ score and performance on neurocognitive tasks (see Table 
5). As data obtained from the stop signal task was significantly skewed and as such 
not normally distributed, a non-parametric equivalent, Spearman’s Rho, was used to 
assess the relationship between impairment in inhibition and autistic traits. 
 
 
 
 
  97 
Table 5: Correlations between scores on AQ (total and subscale scores) and scores 
on neurocognitive tasks 
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Note. *Indicates p<0.05. **Indicates p<0.01.  
Abbreviations = AQ: Autism Quotient (Baron-Cohen et al. 2001). EF: Executive Funcion. BADS: 
Behavioural Assessment of Dysexecutive syndrome (Wilson et al. 1996). DKEFS: Delis-Kaplan 
Executive Function System (Delis et al. 2001). ROCF: Rey-Osterrieth Complex Figure Test (Meyers 
& Meyers, 1995). IED: Intra-Extra Dimensional Task, EDS: Extra-Dimensional Shift (Cambridge 
Cognition, 2006). SST: Stop Signal Task (Cambridge Cognition, 2006). TOM: Theory of Mind. 
In contrast to predictions, no significant relationships were identified between 
AQ scores and cognitive abilities in set-shifting (as determined by the IED shift 
task), inhibition, theory of mind, central coherence or TOM.  There were also no 
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significant relationships between AQ and the BADS six elements general measure of 
executive function.    
However, in accordance with predictions, significant negative correlations 
were identified between the contrast scores on the generativity task and the AQ total 
score and AQ subscale attention to detail score (r(18)=-0.48, p=0.03 and r(18)=-0.61, 
p=0.01 respectively. These findings should however be treated very cautiously given 
the number of correlations completed in the analysis and thus the increased risk of 
Type I errors. 
Multiple single case series analysis: 
The individual cognitive profiles of participants 
Individual cognitive profiles were investigated to determine if any of the 
individuals within the current sample have a ‘classic autistic profile’ as defined in the 
hypotheses; deficits in generativity, set-shifting, TOM and general executive 
function, a more detailed focussed processing style and unimpaired inhibition.   In 
order to determine these cognitive profiles, individual strengths and weaknesses were 
calculated based on comparison of individual performance (scores) on each 
neurocognitive task with the normative mean for that task. Strengths and weaknesses 
are defined as individual scores which deviate from the normative mean for that task 
by more than one standard deviation (based on the standard deviation of the 
normative sample) (see Table 4 for normative means and standard deviation for each 
neurocognitive task).  The direction of the deviation determines if it is a weakness or 
strength.   When the deviation was within one standard deviation of the normative 
mean then the individual’s score was considered to be within the ‘normal’ range for 
that task.   
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Performance on the general executive function task (BADS six elements task) 
seemed to be at ceiling for the current clinical population; all participants fell within 
the ‘normal’ range for this task.  Therefore, the result of this task for each individual 
in determining the match with the classic autistic cognitive profile has been 
excluded. 
Table 6: Analysis of the individual cognitive profiles of participants; areas of 
strength, weakness and normal performance. 
 
Abbreviations = S=Strength. W=Weakness. N=Normal. EF: Executive Function. BADS: Behavioural 
Assessment of Dysexecutive syndrome (Wilson et al. 1996). DKEFS: Delis-Kaplan Executive 
Function System (Delis, Kaplan & Kramer, 2001). ROCF: Rey-Osterrieth Complex Figure Test 
(Meyers & Meyers, 1995). IED: Intra-Extra Dimensional Task (Cambridge Cognition, 2006). SST: 
Stop Signal Task (Cambridge Cognition, 2006). 
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Two individuals (10% of the sample; participant numbers 4 and 14 in Table 
6) clearly demonstrated the classic autistic cognitive profile with deficits in each 
cognitive domain apart from inhibition.  One participant (participant number 13 in 
Table 6) demonstrated the classic autistic cognitive profile apart from demonstrating 
a normal performance in TOM.  However, it should be noted that this ‘unimpaired’ 
performance in TOM was only 0.4 points from being considered a weakness.  
In addition, three participants (15%, participant numbers 2, 9 and 20 in Table 
6) demonstrated weak or normal performances in all cognitive domains apart from 
inhibition in which they demonstrated a cognitive strength. 10% (N=2, participant 
numbers 7 and 17 in Table 6) demonstrated weak or normal performances in all 
cognitive domains apart from inhibition and TOM in which they demonstrated 
cognitive strengths. 
The AQ scores of these 8 individuals identified as having cognitive profiles 
similar to the classic autistic cognitive profile are detailed in Table 7. 
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Table 7: AQ scores of participants with cognitive profiles similar to the classic 
autistic profile 
 
Note:  Minimum and maximum scores attainable on each AQ subscale are 0 and 10 
respectively.  For each subscale, a higher score indicates a higher level of autistic 
traits. 
 
This multiple single case series methodology is exploratory and has been 
employed in place of traditional group-level statistics in order to provide an in-depth 
examination of individual patterns of cognition. In contrast to predictions, there was 
no evidence for a relationship between individual AQ score and similarity in 
individual neurocognitive profile to the ‘classic autistic profile’.  Instead the 
participants highlighted, who have cognitive profiles which are more aligned with 
this autistic profile, have total AQ scores ranging from 10 to 35.  However, seven of 
these eight participants had relatively high AQ scores, scoring above the average AQ 
score (16.4) for the normative population (Baron-Cohen et al. 2001).  
In addition, two of the three participants with AQ scores above the proposed 
cut off for clinically significant levels of autistic traits (32+) have profiles which are 
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8 
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similar to the ‘classic autistic profile’, although neither of these match this cognitive 
profile exactly.   
Results of an independent samples t-test comparing the mean AQ scores of 
those individuals with (M = 25.50, SD = 8.09, N=8) and without autistic cognition 
(M = 24.67, SD = 6.40, N=12) show that there is no significant difference, or any 
trend towards significance, (t = -0.26, df = 18, p = 0.80) between group scores. 
However, clearly the numbers included in this analysis do not provide sufficient 
power to identify relationships of interests and as such these findings should be 
considered extremely cautiously.  
Discussion 
In accordance with predictions and the results of previous research (Anholt et 
al. 2010), elevated levels of autistic traits were identified on the AQ in the current 
sample of individuals with OCD. However, results relating to associations between 
self-reported autistic traits and autistic cognition were ambiguous and multiple single 
case series analysis did not suggest that, in individuals with OCD, there is a subset 
with both elevated autistic traits and cognition.  Whether these elevated AQ scores 
reflect genuine autistic traits, and whether some individuals with OCD have 
neurodevelopmental aetiology akin to ASD, has therefore not been verified.  
Evidence of elevated traits of ASD in OCD 
The finding that eight participants (40%) within the study demonstrated likely 
clinically significant levels of autistic traits is consistent with previous research 
indicating an elevated rate of autism within OCD (25%) (Russell et al. 2005) 
compared to normative populations, adding weight to the possibility that there may 
be individuals with OCD who have more of a neurodevelopmental aetiology akin to 
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ASD.  Interestingly, participants demonstrated elevated scores on the AQ across all 
domains associated with ASD apart from attention to detail.  This is consistent with 
previous research demonstrating that this subscale was the only AQ domain which 
did not predict OCD symptoms or severity (Anholt et al. 2010). Attention to detail is 
thought to be a measure of an individual’s tendency towards detail-oriented attention 
and repetitive behaviours (Baron-Cohen et al. 2001).  It has been suggested that this 
may be a dimension of autism which is relatively independent of its other features 
(Hoekstra, Bartels, Cath & Boomsma, 2008; Hurst, Mitchell, Kimbrel, Kwapil & 
Nelson-Gray 2007).  The higher AQ scores for individuals with OCD on all elements 
of the AQ apart from attention to detail imply that overall scores are not simply being 
inflated by constructs related to repetitive OCD behaviours but that other 
characteristics are contributing to the outcome.  The possibility that individuals with 
OCD may share some but not all traits associated with ASD is consistent with the 
fractionation theory of ASD which suggests that social and non-social symptoms of 
ASD have distinct causes at the genetic, neural, cognitive and behavioural levels 
(Happé & Ronald, 2008; Happé, Ronald & Plomin, 2006). 
However, it is unclear whether this apparent elevation of self-reported autistic 
traits represents genuine ASD symptomatology, as opposed to non-autistic 
difficulties with socialising and communication. This is particularly pertinent given 
the significant correlations identified between measures of trait anxiety and 
depression and scores on the AQ, which brings into question the specificity of the 
AQ.  Similar relationships between these measures of clinical symptomatology have 
been identified in previous research leading to questions around whether the AQ is 
specifically measuring autistic traits or merely incorrectly identifying depressive or 
anxious symptoms as autistic traits (Liew, Thevaraja, Hong & Magiati, 2015). 
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Although there is published evidence of the psychometric value of the AQ (Baron-
Cohen et al. 2001), there is some emerging research criticising its comparative value 
in accurately identifying autistic traits.  For example, in a study comparing the 
psychometric properties of self-report measures of the broad autism phenotype, the 
AQ was found to have the weakest performance (Ingersoll, Hopwood, Wainer & 
Donnellan, 2011). Additionally, the validity of results of self-report measures such as 
the AQ will, by their nature, be impacted by the introspective ability and level of 
understanding of the individuals answering them, which may be particularly relevant 
in populations with high levels of ASD traits/symptomatology (Bishop & Seltzer, 
2012). 
If the AQ is not actually measuring autistic traits but is in fact more a 
reflection of mood, it is not appropriate to assume that higher scores on the AQ 
represent genuine ASD symptomatology in this OCD group. However, it should be 
noted that individuals with ASD are thought to be particularly vulnerable to mental 
health difficulties such as depression and anxiety (Tantam & Prestwood, 1998); thus 
it might be that these positive relationships between autistic traits and symptoms of 
anxiety and depression reflect this increasing vulnerability.   
The analysis of neurocognitive profiles within the current sample and their 
relationship to the self-reported autistic traits was designed to address the question of 
the validity of any self-reported autistic traits identified. 
Do these elevated AQ scores represent genuine autistic symptomatology in 
OCD? 
Results demonstrated that individuals with OCD, compared to normative 
populations, had lower IQ, impairments in some set-shifting tasks and a more detail-
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focussed style of processing.  Taken broadly, this provides some tenuous support for 
individuals with OCD having neurodevelopmental aetiology since an 
impaired/atypical cognitive performance and lower than average IQ would be 
anticipated for individuals with neurodevelopmental disorders like ASD that stem 
from atypical development of the brain (Tager-Flusberg, 1999). 
However, high levels of depression and anxiety identified within the current 
population may explain the lower IQ; research suggests that these mood disorders 
can affect cognition by biasing attention, perception and memory and interfering 
with executive function (Chepenik, Cornew & Farah, 2007). 
It is of note that, consistent with previous research (Chamberlain et al. 2007), 
there may be significant impairment in set-shifting within an OCD population since 
this is a well established area of impairment in ASD.   Perhaps set-shifting in OCD 
warrants further exploration in relation to other indications of atypical 
neurodevelopment, for example, neurological signs and age of OCD onset. 
Central coherence is an area of cognition hitherto largely neglected in OCD 
research.  These findings suggest that further investigation is warranted to determine 
if a more detailed style of processing is, at least for some with OCD, a stable 
characteristic and as such an endophenotype as has been proposed for individuals 
with ASD (Frith & Happé, 1994).   All other areas of cognition were unimpaired 
compared to population norms, including inhibition, which contrasts with previous 
research into OCD cognition (Chamberlain et al. 2005).  
Contrary to predictions, no clear neurocognitive profile was elucidated in 
relation to autistic traits and, given the limited power of the study, the results indicate 
that if these relationships do exist they are unlikely to be large in effect. The 
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hypothesis that individuals with greater levels of autistic traits would demonstrate 
greater impairments in certain areas of cognition (generativity, set-shifting and 
TOM) alongside weak central coherence and greater inhibitory control is 
unsubstantiated. 
However, negative correlations were identified between the contrast scores 
on the generativity task and scores on the AQ total and attention to detail subscale. 
Although this task is designed mainly to measure generativity, the contrast scores 
also indicate ability to shift attention and abilities in non-verbal fluency.  It may be 
that within an OCD population there are individuals with higher levels of ASD traits, 
particularly in the autistic domain attention to detail, which are underpinned by 
difficulties with generativity and set-shifting.  The significance of these findings is, 
however, undermined by the number of correlations completed and thus the elevated 
risk of Type I error.  However, the possibility that assessing performances in 
generativity and set-shifting in an OCD population may provide one means of 
identifying individuals more likely to have neurodevelopmental aetiology like ASD, 
warrants further investigation in a study with greater power.  
The results also present some interesting possible trends (defined as those 
relationships with an alpha value, p<0.1) between specific cognitive domains and 
autistic traits, which certainly cannot be assumed to represent true relationships 
within the data, but may highlight areas of interest for further research with larger 
samples.  For example, in accordance with predictions, a trend was identified 
between better inhibitory control and greater levels of autistic traits in attention to 
detail.   
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It has not been verified by the results of the group analyses correlating 
cognitive profiles and self-reported autistic traits that these elevated AQ scores 
represent genuine ASD symptomatology. However, the results highlight interesting 
areas for future exploratory research and, taken together with group comparisons of 
neurocognitive performance with normative populations, indicate there may be some 
neurodevelopmental aetiology in OCD populations.  
Is there an ASD subgroup? 
The exploratory multiple single case series analysis provides some tenuous 
descriptive support for the theory that some individuals with OCD have atypical 
neurodevelopment, similar to that seen in ASD; three participants (15%) presented 
with the ‘classic autistic profile’.  However, although each of these participants 
scored above the mean AQ for a normative population as determined by Baron-
Cohen et al. (2001) (M=16.4), none scored above the proposed cut offs (32+ or 26+) 
for a likely diagnosis of autism.  Broadening the definition of the ‘classic autistic 
profile’ to include those with marked strength in inhibition (which research indicates 
would be unexpected in an individual with OCD but not necessarily in an individual 
with a neurocognitive profile akin to ASD) and normal or weak performances in all 
or all but one of the other cognitive domains assessed resulted in identification of 
eight individuals (40%) who might be considered to have this broader autistic 
cognitive profile.  Identifying participants in this way captured two of the three 
individuals who attained AQ scores above the higher cut off (32+) for a likely 
diagnosis of autism. This study clearly did not have sufficient numbers and therefore 
power to determine if this group of eight individuals might be meaningfully distinct 
(in terms of their self-reported autistic traits) from the twelve individuals without this 
autistic cognition. However, it is of interest that comparison of mean AQ scores 
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between those with and without this autistic cognition, provides no indication 
whatsoever of difference.  
The results provide insufficient evidence to support the hypothesised 
relationship between this ‘classic autistic cognitive profile’ and higher autistic traits 
in OCD.  It remains unclear whether there is a subgroup of individuals with OCD 
who reflect those with ASD.  
Research limitations and strengths  
The findings described above should be considered cautiously in light of the 
limitations of the AQ described above and the following methodological limitations.  
The small sample size included in this study, resulting from substantial 
recruitment difficulties (see critical appraisal), limits the power to detect meaningful 
differences and important associations may have been missed. On the other hand, the 
number of correlations and analyses completed will have raised the risk of Type I 
errors and it could be that the associations found are a product of this error rather 
than representing real relationships of interest.  The small sample size leaves the 
results of group analyses vulnerable to being skewed by non-representative 
participants or anomalous results.  Thus, results are potentially unrepresentative of 
the wider OCD population meaning that their generalisability is impacted.  
The lack of a control group and reliance on normative means to complete 
group comparisons represents a key weakness in the reliability of these findings and 
results of these comparisons should be considered cautiously, as estimates. 
The specificity of the neuropsychological measures needs to be considered as 
these are rarely specific to a single cognitive domain and often demand numerous 
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underlying cognitive processes for completion (Brunsdon & Happé, 2013).  
Although care was taken to select neuropsychological tasks, which were supported 
by research to tap into the relevant cognitive domains, in some instances this 
specificity was unobtainable.  For example, research suggests that poorer 
performance on the Rey Complex Figure Task reflects weaker central coherence 
(Lezak, Howieson, Loring, Hannay & Fischer, 2004; Spreen & Strauss, 1998) but 
that this also reflects weaker visuoconstructional ability and visual memory (Webber, 
Riccio & Cohen, 2012).  Attempting to determine the prevalence of a specific 
cognitive profile using these neurocognitive measures is therefore potentially limited 
by their lack of specificity.  
One strength of the study is that it screened for mood disorders and thus 
controlled for the possibility that neurocognitive deficits might be mediated by mood 
rather than neurodevelopmental processes, a factor which has limited previous 
research in this area (Delorme et al. 2011; Zandt et al. 2007).  In addition, this study 
is the first to explore an overall neurocognitive profile for OCD rather than describe 
performance on a narrow range of neurocognitive tests. 
Conclusions 
The results of the current study provide some preliminary evidence for the 
theory that some individuals with OCD demonstrate cognitive profiles suggestive of 
atypical neurodevelopment, including lower overall IQ, impaired performances on 
some neurocognitive tasks and heterogeneous cognitive profiles.  However, the 
results have not provided clear evidence to support the theory that some individuals 
within this population really do have traits of high functioning autism.  It is likely 
that the apparent elevated autistic traits identified by the AQ in this OCD population 
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do not represent genuine ASD symptomatology.  Nevertheless, the apparent 
disconnect between AQ scores and neurocognitive profiles may not necessarily 
reflect the absence of an autistic subgroup within the OCD population.  The 
following explanations for these results should also be considered.  
The first explanation relates to the fractionation theory of autism (Happé et al. 
2006).  It may be that rather than a subgroup with ASD existing within the OCD 
population, as theorised by Bejerot et al. (2001), there are individuals with OCD who 
present with some specific autistic traits underpinned by certain cognitive deficits but 
not with the complete cognitive profile or set of symptoms associated with ASD. 
Fractionation of the cognitive ASD profile within the OCD population might explain 
the varied group results in relation to overall associations between autistic traits and 
cognitive deficits within this population.  
Another possible explanation is that a clear ‘autistic cognitive profile’ does 
not exist and the ambiguous results reflect an attempt erroneously to match traits of 
autism in an OCD population to a pattern of cognitive strengths and weaknesses that 
is not reliably associated with ASD. This would be consistent with research which 
suggests that relationships between cognitive test performance and real-life 
behaviour in ASD is inconclusive (Brunsdon & Happé , 2013 ) and the proposal that 
heterogeneity of cognitive profile within and between individuals with ASD is a 
defining feature of the disorder (Towgood et al. 2009). Thus, the lack of support for a 
link between the ‘classic autistic profile’ and AQ scores in the current study may 
simply reflect an erroneous means of identifying an autistic subgroup within the 
OCD population.    
  111 
It may be that a subgroup with ASD traits does exist within an OCD 
population but it was not clearly identifiable in this study as a result of measurement 
error and the small sample.  The AQ may not have captured traits of autism 
accurately and specifically (due to potential limitations described above), thereby 
obscuring clear results pertaining to a relationship between ASD traits and a ‘classic 
cognitive autistic profile’. This would support the finding that there was a mismatch 
between individuals within the current sample who demonstrated a ‘classic cognitive 
autistic profile’ and those who attained clinically significant AQ scores.   
Future directions for research 
The heterogeneity of cognitive profiles within this small population of 
individuals with OCD was notable. This heterogeneity suggests that individuals with 
OCD may be characterised by highly variable cognitive profiles or that numerous 
subgroups with distinct neurocognitive patterns exist within this population as 
previously suggested by Nedeljkovic et al. (2009). The multiple single case series 
analysis, piloted with this population in the current study, has provided some 
interesting findings with regard to identifying individuals with similar cognitive 
profiles in a heterogeneous group. This research has highlighted the value of multiple 
single case series analysis in an OCD population and suggests further research is 
warranted using this approach (not based on group design and averages which may 
preclude identification of subgroups) but with greater numbers and therefore power 
to discriminate subgroups.  
Repetition of the study with greater numbers of participants might elucidate 
more clearly relationships between autistic traits and cognitive strengths and 
weaknesses in OCD and support clearer identification of specific subgroups within 
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OCD such as one well described according to ASD traits. It would also be advisable 
to employ a more objective measure of ASD symptomatology and traits, such as the 
ADOS (Lord et al. 2001), which is clinician administered and uses behavioural 
observations to determine presence of autistic traits, meaning it is less likely to be 
subject to measurement error than the self-report AQ.  
Given the preliminary evidence suggesting some atypical neurodevelopment 
within the current sample of individuals with OCD it would be interesting to explore 
the nature of this hypothesised neurodevelopment in OCD in more detail. As 
neurodevelopmental disorders emerge in childhood it would be interesting to 
investigate changing cognitive processes and autistic traits in children with early 
onset OCD in a longitudinal designed study. 
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Introduction 
This appraisal will reflect on some of the practical and conceptual issues 
encountered in the process of conducting this research. The impact of some of the 
methodological weaknesses, such as difficulties with recruitment and data collection 
and limitations of statistical analyses employed, will be discussed, as will ethical and 
practical considerations of carrying out research with a population with complex 
mental health difficulties.  The benefits of conducting joint research will be 
highlighted and recommendations made for future research. 
Origins of the study and motivation for the research 
I was motivated to undertake a project related to autism spectrum disorders 
(ASD) following three years’ experience (pre-clinical psychology training) of 
working with this clinical group.   Having observed the diversity both in symptom 
expression and severity, which was apparent in the individuals with ASD with whom 
I had worked, I was interested in exploring the theoretical conceptualisation and 
perception of some disorders as spectrum disorders and the potential for symptom 
fractionation in autism.  The fractionation theory of autism suggests that social and 
non-social symptoms of ASD have distinct causes at the genetic, neural, cognitive 
and behavioural levels (Happé, Ronald, & Plomin, 2006; Happé & Ronald, 2008), 
which opens up the possibility that certain dimensions of autism or autistic traits (in 
the absence of others) could be shared by other disorders. 
The publication of the DSM-5 (American Psychiatric Association, 2013) saw 
obsessive compulsive disorder (OCD) reconceptualised under the Obsessive 
Compulsive Spectrum Disorders category, acknowledging a shift in perception of 
this disorder to a heterogeneous diagnostic entity.  During my work in autism 
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services I had encountered a number of individuals with comorbid diagnoses of OCD 
and ASD and had noted confusion regarding symptom overlap and as a consequence 
the interventions offered.  The profound impact of both disorders on quality of life 
for individuals and their families and/or care systems if inadequate or inappropriate 
support is provided is well documented (Renty & Roeyers, 2006; Subramaniam, Soh, 
Vaingankar, Picco & Chong, 2013). This motivated my research into the relationship 
between these disorders with the objective that findings might elucidate areas of 
overlap and inform more appropriate treatment packages.          
Methodological considerations of the Empirical Study 
Ethical considerations 
Directly recruiting from a single NHS outpatient service and testing at this 
site was considered to be ethically appropriate given the complex and chronic nature 
of the mental health presentations of many of the individuals being cared for by the 
service.  Specifically it was thought that familiarity with this service and structure 
would support both the comfort of the participants during their participation in 
research and the management of risk as each individual was well known to and had 
been recently seen by clinicians in the service.  Being embedded in the service as a 
researcher with access to clinicians who were clinically responsible for participants, 
afforded participants quick access to appropriate professional support should any 
difficulties arise during the research process.  However, in retrospect, it may be that 
our placement within the clinical team, together with our title of Trainee Clinical 
Psychologist, could have presented some confusion to participants about our role as 
researchers rather than clinicians.  Although our role as researchers was clearly 
defined and explained to participants at both the recruitment and testing phases of the 
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research and outlined within the Participant Information Sheet, participants 
frequently let us know the degree of distress they were experiencing with a minority 
expressing suicidal ideation.   This was easily managed during the testing sessions 
which were located within the service where their clinical team was based so that 
immediate support for them from appropriate clinicians could be arranged.  
However, expressions of extreme distress and suicidal ideation were also 
encountered on a few occasions over the phone during the process of recruitment.  In 
these cases it seemed that potential participants were regarding us as part of their 
clinical care team.  Although protocol was in place for the management of these 
situations (to develop a safety plan over the phone with the individual and 
immediately contact the clinical team and/or emergency services as appropriate), it 
raised questions as to the participants’ understanding of the limits of our roles and 
whether this information would have been shared with us had this understanding 
been in place.  Practically we were limited as clinicians as we had restricted 
background clinical information for each potential participant so that we could 
remain blind to their likely presentation during the testing phase.  This presented an 
ethical question as to whether it was possible and/or appropriate to manage risk as a 
clinical researcher whilst also remaining blind to the complexities of a participant’s 
presentation.  Although risk was managed adequately, perhaps in retrospect, given 
the severity of the mental health difficulties of a number of potential participants, a 
more thorough screening process should have been implemented so that we were 
informed by the service clinicians of individuals likely to be in particular distress 
before we made contact about their participation in our research. This might have 
protected potential participants from divulging information to us that they might 
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otherwise not have done and allowed for clearer delineation of our roles as 
researchers rather than clinicians.  
Recruitment of clinical participants 
Directly and solely recruiting from a pool of individuals who had already 
completed some related research and had given consent to being contacted for future 
related research was considered to be an efficient recruitment strategy at the start of 
the research process.  Indeed, before starting the research, we had been assured by 
the service in which the study was taking place that we would be able to achieve 
sufficient numbers for our project with ease.  However, as the research progressed it 
became clear that this dependency on a single service and participants from previous 
related research created some unforeseen limitations to progressing recruitment.   In 
retrospect, recruitment of participants presented the most significant practical 
challenge of the research process and difficulties encountered necessitated a study 
redesign.  Specifically, the original design of the study had been to divide 
participants, according to their scores on the AQ, into those with higher and lower 
autistic traits and compare cognitive profiles between these two groups.  An original 
power analysis was calculated based on a large effect size (d=0.87) found in a 
comparable study which discriminated individuals with ASD from typical controls 
according to executive function using the CANTAB (Ozonoff et al. 2004). It was 
determined that an appropriate sample size would be 18 in each group to detect 
significant group differences.  
Unfortunately, as the research project on which our recruitment relied was 
progressing alongside our research project, the clinicians and researchers were very 
involved in their own recruitment and struggled to find time to provide us with 
  132 
information regarding those participants who had provided consent to be contacted 
regarding future research.  We were instead provided with approximately five names 
and contact numbers every few weeks which was considerably fewer than the 
anticipated number of participants promised at the outset and from which we 
expected to recruit.  This significantly impacted the progress we could make in 
recruitment.  Service instability and pressures contributed to this disappointing 
recruitment process.  Specifically, there was an imminent threat of service relocation, 
which had left the service, its systems and its employees in a state of flux, making it 
difficult for individuals working within this service to keep our research and 
requirements in mind. Numerous strategies were implemented to speed up the 
recruitment process including supporting the clinicians with the administrative 
burden of identifying potential participants and attending clinic days to introduce 
ourselves and the project to possible participants where appropriate before asking for 
any commitment to the research.  This however was not a straightforward process as 
disorganised filing systems made identification of potential participants extremely 
difficult and clinic days seemed to change without warning leading to much time 
wasting.  Ultimately the related research project on which we relied was only able to 
deliver a pool of 54 potential participants for us to recruit from. It therefore became 
apparent before the end of our recruitment phase that the possibility of attaining 
sufficient sample numbers to complete group comparisons as initially planned was 
unrealistic. The design of the study was necessarily reconceptualised to 
accommodate the smaller sample size attainable; hence the use of correlational and 
multiple single case series analysis.   
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Statistical analyses   
The small sample size in the current study presented some challenges in 
design as the study lacked sufficient power to use group analyses such as the t-test. 
Fortunately the breadth and amount of data collected for each participant was 
considerable and enabled the use of both correlational analyses and a novel and 
interesting analytic approach within the OCD population, multiple single case series 
analysis. This methodology has been employed successfully in furthering 
understanding of cognitive deficits both in populations with neurodevelopmental 
disorders such as ASD (Towgood, Meuwese, Gilbert, Turner & Burgess, 2009) and 
in other populations such as in schizophrenia (Shallice, Burgess & Frith, 1991) and 
allows for exploration of heterogeneity within populations which might support 
identification of sub-groups.  As such, in relation to the current research question, 
this methodology was extremely apt.  The interesting findings that were elucidated 
from the analyses of the current study however are limited by the small sample size 
in terms of their generalisability to the wider OCD population and research 
employing this methodology alongside group analyses with greater numbers of 
participants would be of interest.   
In addition, due to the exploratory nature of this study, multiple statistical 
tests were used which may have increased the risk of type-I error, (making a false 
positive result). In contrast the low power of the study will have increased the risk of 
type-II error (making false negative results). Both these possibilities bring into 
question the reliability and meaningfulness of results attained in the current study; 
thus it would be recommended that these findings are used for the purposes of 
identifying areas of interest for future research which would benefit from the use of a 
larger sample to allow for more robust statistical analyses. 
  134 
Selection of neurocognitive measures and mood screens 
Selection of the neuropsychological measures and mood screens was made 
with awareness of the cumulative time required for completion to ensure that testing 
would not be over burdensome and tiring for participants. This was to ensure that 
participants were able to give their best efforts.  A calculation was made that the 
testing phase should take approximately 2 hours for those without mental health or 
cognitive difficulties.  Taking into consideration the impact that OCD might have on 
an individual’s ability to progress through the tasks at a typical pace, testing sessions 
of 3 hours were scheduled on the assumption that this would allow for frequent 
breaks when necessary and longer time for completion.  However, this research 
process has highlighted how difficult completing a comprehensive battery of testing 
with participants with OCD can be, when their levels of disability and distress are 
profound and significantly impact their ability to progress through the research tasks.  
For example, although for most participants 3 hours was sufficient, for some 
it became clear that testing within this time frame was neither practical nor ethical as 
they struggled to progress from one item to the next. In these instances judgements 
were made to extend testing time allowing for extended breaks to reduce any 
pressure that might be felt by participants to complete within a given time frame.  
Completion of questionnaires presented one of the more significant stumbling blocks 
for many participants with OCD who were often crippled by uncertainty about 
providing ‘just the right’ answer. Indecisiveness, intolerance of ambiguity and the 
need for reassurance are characteristics commonly associated with OCD, which have 
been identified as potentially interfering with assessment processes 
(Swinson, Antony, Rachman & Richter, 1998). Numerous strategies were therefore 
introduced to support completion including gentle encouragement, allowing 
  135 
participants to find a quiet place where they could answer questions alone and/or 
providing large visual aids which displayed the options for answers more clearly.  
Preferences for delivery of the questionnaires were also explored with participants, 
as some found auditory processing more accessible.   In these instances we would 
read out the items on each questionnaire to support understanding.  A dictionary was 
also made available so that, should the participant wish, they could confirm their 
understanding of statements or questions. These supportive measures were 
introduced to balance the provision of sufficient and appropriate time per item with 
the awareness that it was important to prevent the individual from becoming stuck 
and caught up in the uncertainty of providing a ‘correct’ answer, which might cause 
undue distress.  Without exception participants expressed a sense of accomplishment 
and achievement once they had progressed successfully through the research process 
and therefore ensuring their success in completion was a priority.  However, without 
this flexibility in time to accommodate differences in abilities, success may not have 
been supported which might have had a negative impact on participants’ sense of 
well-being.  Future research, which aims to complete a comprehensive battery of 
testing with participants with OCD, should be designed to accommodate these 
variances in ability and to anticipate challenges so that individuals can, as above, be 
supported appropriately to succeed in completing the research.  
Other considerations 
Impact of comorbidity and medication on cognitive performance 
Comorbidity and use of medication within the current sample population was 
high; 70% of participants had at least one physical or mental health disorder 
comorbid with OCD and 100% of participants were taking at least one form of 
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medication for mental health difficulties at the time of the study.  It was not possible 
to exclude participants on the basis of comorbidity or medication use given the 
prevalence of these factors within the population from which we were recruiting.  In 
addition it was thought that this level of comorbidity and medication use might be 
more representative of the wider population of individuals with OCD (Chamberlain, 
Blackwell, Fineberg, Robbins, & Sahakian, 2005) potentially making the results of 
this study more generalisable.  Criticisms of previous research into cognitive deficits 
within an OCD population have highlighted the failures of studies to screen for or 
consider the contribution of comorbidity to cognitive profiles (Kuelz, Hohagen & 
Voderholzer, 2004).  Specifically, ignoring the impact that primary mood disorders, 
such as depression or anxiety, might have on neurocognitive performance has been 
highlighted as a particular flaw in previous research (Chamberlain et al. 2005).  The 
current study attempted to manage these potentially confounding factors by 
screening for levels of depression and anxiety using psychometrically sound 
assessment tools (the MADRS (Montgomery & Asberg, 1979) and the STAI 
(Spielberger, Gorsuch, & Lushene, 1970) respectively) and controlling for the impact 
of these on cognitive performance in statistical analyses.  It was not possible or 
appropriate, however, given the time constraints and number of analyses already 
being completed, to screen independently and control for the impact of each 
comorbid condition or medication on cognitive performance.  However, the impact 
of medication, or of comorbid conditions, common in OCD, on cognitive 
performance may be interesting areas to explore in future research with greater 
resources, time and sample sizes.  This may elucidate further the complex 
relationship between OCD and cognitive deficits.       
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Joint work  
This research was completed jointly with Josselyn Hellreigel (see Appendix 2 
for details).  There were various benefits to sharing the research process; principally 
it allowed us to share the burden of recruitment and testing participants, both time 
consuming processes, and supported the recruitment of more participants than would 
have been possible independently.  Had this process not been shared we would have 
been trying to recruit from the same small pool of potential participants which might 
have created unnecessary competition between the projects to recruit the same 
participants.  Working together meant that we were able to pool our financial 
resources which allowed us to contribute to the cost of participants’ travel.  This was 
key in securing as many participants’ engagement in the research as possible, as 
many participants lived some distance from the national OCD service where the 
testing took place and the cost of their travel was often cited as a significant barrier 
to their participation.    
As we were embedded within a clinical team who were completing associated 
research there were significant opportunities for sharing knowledge and resources.  
However, the benefits of working as a research team in this way went beyond 
providing a forum for mutual learning and development as it also created an 
environment which promoted motivation and provided support when obstacles to the 
research process presented themselves.    
Conclusions 
The issues considered above highlight the methodological and ethical 
complexities inherent in conducting research with a clinical population with 
significant mental health difficulties such as OCD. Although adjustments were 
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required both in the research design and the empirical methods employed to ensure 
successful completion of the research, this study has demonstrated that, even with 
small sample sizes, when the appropriate level of flexibility is afforded, meaningful 
research can be completed with people with complex OCD.   
This research has provided some interesting results regarding the likely 
prevalence of atypical neurodevelopment within OCD which may, at least in part, be 
associated with autism at a neurocognitive level.  The generalisability of these 
findings is impacted by methodological weaknesses such as the small sample size.  
However, the research has identified interesting possible associations between 
evidence of atypical development and autistic traits which can be used to guide 
future research.  In addition the research has successfully piloted a novel statistical 
approach, multiple single case series analysis, within the OCD population in 
exploring neurocognitive profiles and highlighted the strengths of combining group 
and individual analyses in heterogeneous populations.  
On reflection, conducting this exploratory research has been a challenging but 
useful learning process, which has required flexibility and unanticipated adaptations 
to the research design supporting my development as a scientist-practitioner.  The 
research process has added to my clinical understanding of OCD and reinforced my 
interest in spectrum disorders such as autism.  My initial aim to create a piece of 
research with ‘perfect’ clear results has been challenged and replaced by an 
understanding that there is value in exploratory research with clear strengths and 
limitations, which can be used as a platform to encourage future research in an area 
which has been relatively neglected.       
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APPENDICES 
 
Appendix 1 – Participant Information Sheet 
 
 
 
 
 
 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
 
Social style, motivations and reasoning ability of people with OCD 
 
We would like to invite you to take part in our research study.  Before you 
decide whether you would like to participate we would like you to understand 
why the research is being done and what it would involve for you.  One of 
our team will go through the information sheet with you and answer any 
questions you may have.  We suggest this should take about 15 minutes. 
Please ask us if anything is not clear. 
 
PART 1 
 
What is the purpose of this study? 
 
In this study we are interested in further exploring the underlying mechanism 
of the obsessions and compulsions seen in OCD to improve treatment 
outcome.  We are interested in the variation in people’s social style. Some 
people find it more difficult to navigate through social situations. These 
people may have mild symptoms of autism. We are interested if some of the 
obsessions and compulsions might be related to people’s social 
communication style.   
 
If you are interested in taking part we will ask you to complete questionnaires 
and complete puzzles and reasoning problems in order to explore people’s 
social style and reasoning abilities.  Our hope is that the results will help 
inform better treatment packages for individuals with a diagnosis of OCD, in 
particular, better treatment for those who have not benefitted very much from 
the treatment received so far.  
 
Why have I been invited? 
We are inviting participation from patients who have attended or are 
attending Xxxxx Hospital OCD services and who have taken part in the initial 
 
Research Department of Clinical, 
Educational and Health Psychology 
1-19 Torrington Place, WC1E 7HB 
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study being completed by our colleagues in the OCD specialist clinic at 
XXXXX. 
You have been invited because we understand that you have indicated that 
you would be happy to be contacted regarding participation in further related 
studies. 
We are also inviting participation from patients at the XXXXX OCD services 
who, although may have missed the opportunity to take part in the initial 
study, are interested in taking part in this current study.  
Our aim is to recruit two groups of equal number of participants to the study; 
one group who represent those who may have mild autistic traits and one 
group who do not appear have these traits based on the questionnaires you 
have previously completed with your clinical care team at XXXXX. All 
participants will have a diagnosis of OCD. The group results will be 
compared. 
 
 
Do I have to take part? 
No.  Participating in this study is entirely voluntary. It is up to you to decide 
whether to join the study. We will describe the study and go through this 
information sheet. If you agree to take part, we will then ask you to sign a 
consent form. You are free to withdraw or decline to participate at any time, 
without giving a reason. This would not affect your medical care or legal 
rights.  
 
What will I have to do if I take part? 
If you agree to take part we will invite you to Xxxxx Hospital where we will 
ask you to complete three questionnaires about your compulsions, sensory 
experiences (e.g. to noise) and attitudes.   
 
In addition, we will ask you to complete a selection of eight tasks and puzzles 
which will help us get an understanding of your cognitive strengths and the 
things you find more difficult e.g. response inhibition.  Some of these tasks 
and puzzles will be paper based (e.g. joining dots in a drawing) and some will 
be computer based (e.g. pressing a button in response to a picture).   
 
We may ask you to complete up to 4 additional questionnaires about your 
mood and current OCD symptoms. We will only ask you to complete these 
additional questionnaires if you have not already done so recently in a clinical 
appointment at your OCD service.   
 
The questionnaires and tasks should take no longer than 3 hours. You will be 
able to take breaks during the assessment and can reschedule the 
assessment or parts of the assessment for another time if you so wish.   
 
We will make a contribution up to a maximum of £10 to any travel expenses 
with presentation of a travel receipt. 
 
Please refer to the enclosed map for directions.  
 
If I agree to take part what happens to my results? 
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All the information collected is confidential.  Your questionnaires and 
response booklets will be anonymised and be kept locked in an office.  Only 
the researchers involved in this study will have access to this information.   
 
Reporting the study findings 
We will write a report which states group results. We will not include your 
name or any other information about you that can identify you. Nobody else 
will know that you took part in the study.  In other words, we can guarantee 
that information about you will be anonymous because we will talk about 
groups not individuals.   
 
Are there any risks to taking part in the study? 
As we will not be giving you any additional treatment for the purpose of the 
study, there are no specific risks or side effects of taking part in this study. It 
is unlikely that new difficulties would emerge during the participation in this 
study that you were not previously aware of and that have not previously 
been identified by your care team at XXXXX. However, should we identify 
new symptoms such as those indicating ASD traits, low mood, heightened 
anxiety, pronounced difficulties in planning and organisation skills we would 
inform your clinical care team who will consider suitable routes of support if 
necessary.   
We do not think that you will feel distressed as a result of participating in this 
study. If, however, you do become uncomfortable you will be provided with 
the opportunity to debrief with a clinician following the task should you wish.  
As you are part of the OCD clinic professional ongoing support can also be 
provided if necessary. 
 
Are there any benefits to taking part in the study? 
We can not promise that the study will help you but we hope that the 
information that we get from this study can be used to help other individuals 
with a diagnosis of OCD. Specifically we hope that the results will help to 
inform better treatment packages for individuals with OCD and in particular 
will be beneficial to individuals who have not had successful outcomes from 
treatment for OCD provided so far.   
 
What happens when the research stops? 
Throughout the duration of the research, your care at the XXXXX OCD 
service will continue as usual. After completion of the research these 
arrangements will not change and you will still have access to the care 
support of the OCD clinic 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or 
any possible harm you might suffer will be addressed.  The detailed 
information on this is given in Part 2. 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you 
will be handled in confidence as detailed in part 2. 
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PART 2: 
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before making 
any decision. 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the study at any time.  If you do withdraw from 
the study we may still use the data collected up to your withdrawal.   
 
What if there is a problem and how do I make complaints? 
If you have any concerns or questions about any aspect of this study, you 
should contact Dr William Mandy who is managing the study. 
 
Dr William Mandy 
Research Department of Clinical, Educational and Health Psychology 
1-19 Torrington Place, WC1E 7HB 
Tel: 020 7679 1675 
E-mail:  
 
If you wish to complain, or have any concerns about any aspect of the way 
you have been approached or treated by members of staff you may have 
experienced due to your participation in the research, National Health 
Service or UCL complaints mechanisms are available to you.  
 
The Patient Advice and Liaison Service (PALS) can be contacted at: 
Hertfordshire Partnership NHS Foundation Trust 
99 Waverley Road,  
St Albans,  
Hertfordshire  
AL3 5TL 
Tel:  01727 804629 
E-mail: PALS.Herts@hertspartsft.nhs.uk 
 
Please ask your research doctor if you would like more information on this.  
In the unlikely event that you are harmed by taking part in this study, 
compensation may be available.  
 
If you suspect that the harm is the result of the Sponsor’s (University College 
London) or the hospital's negligence then you may be able to claim 
compensation.  After discussing with your research doctor, please make the 
claim in writing to the Dr. William Mandy, who is the Chief Investigator for the 
research and is based at University College London.  The Chief Investigator 
will then pass the claim to the Sponsor’s Insurers, via the Sponsor’s office. 
You may have to bear the costs of the legal action, and you should consult a 
lawyer about this. 
 
Will my taking part in the study be kept confidential? 
If you join the study, some relevant parts of your medical records and data 
collected for the study will be looked at by authorised persons from the 
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sponsor which includes the researchers from UCL and the care staff at the 
OCD services at XXXXX.  They may also be looked at by authorised people 
to check that the study is being carried out correctly. All have a duty of 
confidentiality to you as a research participant and we will do our best to 
meet this duty.  In addition any information, collected during the course of the 
research, which leaves the hospital will have your name and address 
removed so that you cannot be recognised. 
 
What will happen to the results of the research study? 
The broad scientific results of this study will be presented in peer reviewed 
journals and conferences. All data presented is based on a group analysis 
and is anonymised. No individual participant will be identified in any report 
publication.  
 
Who is organising and funding the research? 
This study is being sponsored by the University College London 
 
Who has reviewed the study? 
 
All research in the NHS is looked at by an independent group of people 
called a Research Ethics Committee to protect your interests. This stidy has 
been reviewed and given favourable opinion by London - Harrow Research 
Ethics Committee- REC number: 13/LO/0595 
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Appendix 2 – Details of Joint Work 
This study was conducted jointly with Josselyn Hellriegel (trainee clinical 
psychologist).  
We both required participants from the same OCD service who had taken part 
in an initial pilot study which determined their levels of autistic traits by completion 
of the Autism Quotient (AQ) and as such we jointly recruited and tested participants. 
This meant that some of the data collection for each of our studies was undertaken by 
the other trainee. For example, if Ms. Hellriegel met a participant to complete some 
questionnaires regarding motivational processes in OCD, she would be responsible 
for completing the neurocognitive measures for my study. Likewise, if I met a 
participant to complete the neurocognitive tasks for my study I would be required to 
complete the measures of motivational processes with them for the purposes of Ms. 
Hellriegel’s study. In addition certain data collected, such as the mood 
questionnaires, were required by both separate research projects and jointly testing 
participants prevented the duplication of measure administration. 
If the task of data collection had not been shared, recruitment of participants 
to both studies would have been unwieldy as it would have required each participant, 
who clinically were often quite unwell, to make two rather than one research 
commitment. Sharing the task of recruitment allowed us to individually obtain more 
participants, as the number of people willing and able to attend one rather than two 
recruitment appointments was likely significant. Furthermore, it also allowed us to 
pool our financial resources so that we were able to give participants compensation 
for travel to the clinic. Given that the OCD clinic from which we completed our 
research represented a national OCD service and as such participants often lived 
some distance away from the service, this financial flexibility may have prevented 
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the cost of travel acting as a deterrent to participation and enabled recruitment of 
greater numbers of participants. 
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Appendix 3 – Ethics approval documentation 
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Appendix 4 – Consent form 
 
 
 
Centre Number:  
Study Number: 
Patient Identification Number for this study: 
CONSENT FORM 
Title of Project: Social style, motivations and reasoning ability of people with OCD 
Name of Researcher(s): Caroline Barber and Josselyn Hellriegel 
Please initial all 
boxes  
1. I confirm that I have read and understand the information sheet dated 28 August 
2013 (Version 4) for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
   
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected. 
 
3. I understand that relevant sections of my medical notes and data collected during 
the study may be looked at by the research members from University College 
London, the sponsor, Regulatory Authorities or from the NHS Trust, where it is 
relevant to my taking part in this research.  I give permission for these individuals 
to have access to my records. 
 
4. I agree for my care team to be informed of any additional difficulties arising from 
the research assessments. 
 
5. I understand that by completing and returning this form, I am giving consent that 
the personal information I provide will only be used for the purposes of this 
project and not transferred to an organisation outside of UCL. The information 
will be treated as strictly confidential and handled in accordance with the 
provisions of the Data Protection Act 1998.  
 
Research Department of Clinical, 
Educational and Health Psychology 
1-19 Torrington Place, WC1E 7HB 
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6. I agree to take part in the above study.  
 
            
Name of Participant   Date    Signature 
                                
            
Name of Person taking consent Date    Signature  
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Appendix 5 – Description of neurocognitive tests employed 
Psychometric Tool Construct 
measured 
Description of test 
Wechsler Abbreviated 
Scale of Intelligence 
® -2 subtest version 
(WASI – II) 
(Wechsler, 1999). 
Intelligence This brief assessment consists of two measures; vocabulary 
(measures word knowledge, verbal concept formation, and 
fund of knowledge) and matrix reasoning (measures visual 
information processing and abstract reasoning skills) from 
which a reliable estimate of general intellectual ability can 
be obtained (full scale IQ (FSIQ)). 
 
The modified six 
elements subtest of 
the Behavioural 
Assessment of the 
Dysexecutive 
Syndrome (Wilson et 
al. 1996); 
Overall 
executive 
function 
An ecologically valid measure of executive function (Norris 
& Tate, 2000).  In this test participants must plan and 
organise their time (10 minutes) to complete some of each 
of six separate sub-tasks whilst following predefined rules 
(Towgood et al. 2009). 
 
The intra-extra 
dimensional (IED) 
shift task from the 
Cambridge 
Automated 
Neuropsychological 
Test Battery 
(CANTAB) 
(Cambridge 
Cognition, 2006). 
 
 
Set-shifting 
 
The IED task involves the presentation of a series of screens 
on a tablet computer which demand a touch screen response 
from the participant. The task consists of nine different 
stages of increasing difficulty where participants learn a 
series of nine two-alternative, forced-choice discriminations 
using feedback provided automatically by the computer. 
Participants must achieve 6 consecutive correct responses at 
each stage to progress to the next stage.  Initially 
participants are presented with two simple visual stimuli 
(coloured shapes) and must learn through trial and error the 
rule indicating which shape is “correct”.   Once the rule is 
achieved on six consecutive occasions a new rule is 
introduced which the participant must learn based on the 
feedback from the computer.  In later trials, a second shape 
is transposed onto each shape, so that the participant must 
take another dimension into account when determining 
which shape is correct.  Two critical shifts occur during the 
test, one at the sixth rule change when subjects must shift to 
new exemplars of the most recent dimension (an intra-
dimensional shift) and a second at the eighth rule change, 
where subjects must shift to a second dimension (an extra-
dimensional shift) (Edgin et al. 2010).   
 
Three outcome measures were selected to capture set-
shifting difficulties within the sample population: 
 
EDS errors; the number of errors made at the stage where 
the extra dimensional shift occurs, thought to be a good 
measure of attentional set-shifting 
 
IED Total Errors (adjusted); the number of errors made 
across the whole task, thought to be a good measure of 
performance efficiency, adjusted to account for each stage 
not completed due to failure. 
 
Stages completed; the number of stages completed out of a 
total of 9. 
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Psychometric Tool Construct 
measured 
Description of test 
The Stop Signal task 
from the CANTAB 
(Cambridge 
Cognition, 2006).  
 
Response 
Inhibition 
The Stop Signal task involves the presentation on a tablet 
computer of a series of screens with a white ring, displayed 
to alert the subject. Following a fixed 500ms delay, a visual 
stimulus is displayed within the ring consisting of an arrow 
pointing to the left or to the right.  
There are two parts to the test; the first part is a practice 
round consisting of 16 trials. In this practice round the 
subject is introduced to the press pad and told to press the 
left hand button when they see an arrow pointing to the left 
and the right hand button when they see an arrow pointing to 
the right. The second part consists of five assessed blocks 
each of 64 trials. The subject is told to continue pressing the 
buttons on the press pad when they see the arrows as before, 
but, if they hear an auditory signal (a beep), to withhold 
response and not press the button. The test gives a measure 
of the individual’s ability to inhibit a response.   
 
One outcome measure was selected to capture impairments 
in inhibition (specifically prepotent inhibition) within the 
current sample: 
 
Stop Signal Reaction Time (SSRT); an estimate of the length 
of time between the go stimulus and the stop stimulus at 
which the subject is able to successfully inhibit their 
response on 50% of trials. It is therefore a measure of the 
internal time required to stop the already-triggered motor 
response.  
 
The Revised Eyes test 
(Baron-Cohen et al. 
2001). 
Theory of 
Mind (TOM) 
The Eyes Test is suitable for the detection of mild ToM 
impairments in individuals with HFA and Asperger 
syndrome. Scores on the Eyes Test have been found to be 
negatively correlated to AQ scores (Baron-Cohen et al. 
2001). The test consists of 36 black-and-white photographs 
of the eye region which are presented separately and in a 
specified order. In each trial, participants are instructed to 
choose a descriptor from four choices which they believe is 
the best match to describe what the person in the photograph 
was thinking or feeling. This procedure requires participants 
to make decisions with regard to the mental states of others.    
 
The Rey-Osterrieth 
Complex Figure Test 
(RCFT) (Osterrieth, 
1944); 
Central 
Coherence 
A pen and paper test in which participants are asked to copy 
a complex figure from a piece of paper and then asked to 
recall the figure without previous warning after an interval 
of approximately 3 minutes and then again after an interval 
of 30 minutes. Lower rates of recall often suggest a more 
detail-focused style (Spreen & Strauss, 1998; Lezak et al. 
2004).  
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Psychometric Tool Construct 
measured 
Description of test 
The design fluency 
subtest from the 
Delis-Kaplan 
Executive Function 
System (D-KEFS) 
(Delis, Kaplan & 
Kramer, 2001). 
Generativity This test is a nonverbal variant of the verbal fluency test. It 
is based on earlier versions of the task, such as Design 
Fluency (Jones-Gotman & Milner, 1977).  This is a pen and 
paper task which requires the production of as many 
different line-drawing designs by connecting a series of dots 
according to predefined rules within a delineated time 
period.  There are three separate conditions with differing 
predefined rules; conditions 1 and 2 involve connecting 
either filled or empty dots whereas condition 3 involves 
switching between empty and filled dots which increases 
cognitive load. 
 
Three outcome measures (Delis, Kaplan & Kramer, 2001) 
were selected to capture impairments in generativity in the 
current sample: 
 
Total correct designs completed; representing the total 
number of correct designs completed across all three 
conditions. 
 
Composite score; representing the total number of correct 
designs generated in conditions 1 and 2. This captures the 
participant’s non-verbal generativity without having to 
engage in simultaneous cognitive switching. 
 
Contrast score; representing the total number of correct 
designs generated in condition 3 as compared with the 
composite score. As such this score represents the 
participants’ ability to generate designs with set-shifting 
relative to their ability to generate designs without set-
shifting.   The contrast score therefore provides a measure of 
the degree to which a participant may exhibit an impairment 
in set-shifting above and beyond any deficits in non-verbal 
generativity. 
 
The State-Trait 
Anxiety Inventory 
(STAI) (Spielberger 
et al. 1970).   
 
Anxiety 
 
The STAI is a widely used measure of state and trait anxiety 
which has both State and Trait scales. Each scale consists of 
20 self-report items that are rated on a 4-point Likert scale. 
The STAI has demonstrated good psychometric properties 
(Barnes, Harp, & Jung, 2002); a higher score on each scale 
represents higher levels of anxiety. 
 
The Montgomery-
Asberg Depression 
Rating Scale 
(MADRS) 
(Montgomery & 
Asberg, 1979). 
 
Depression 
 
The MADRS is a clinician rated 10-item scale designed to 
measure symptoms of depression.  Each item is rated on a 7 
point scale (0 to 6) and higher total scores indicate higher 
levels of depressive symptoms. The MADRS has 
demonstrated good psychometric properties (Montgomery & 
Asberg, 1979). 
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Appendix 6 – Description of OCD treatment stage: 
 
Treatment 
stage 
Description 
1 Treatment Naïve. 
2 Inadequate course of evidence based treatment. 
3 Responded to course of treatment. 
4 Failed one course of CBT or evidence based pharmacological treatment 
with good       adherence. 
5 Failed 2 courses of CBT or 2 courses evidence based pharmacological 
treatment with good adherence. 
6 Failed 2 courses of CBT including home based therapy or evidence 
based Pharmacological therapy augmented with antipsychotic or high 
dose SSRI. 
7 Failed 2 coursed of CBT including inpatient CBT or augmentation of 
evidenced based pharmacological therapy. 
 
Note.   
Treatment stage defined and assessed by clinicians based within the OCD clinic in which the 
research took place. 
 
Appendix 7 – Source of normative data for neurocognitive tasks: 
 Central Coherence – normative data taken from the Rey Complex Figure Test 
and Recognition Trial: Professional Manual (Meyers & Meyers, 1995) 
 Generativity – normative data taken from the DKEFS Examiner’s Manual 
(Delis, Kaplan & Kramer, 2001) 
 Inhibition – Official normative data for the Stop Signal Task is not yet 
available from Cambridge Cognition (Cambridge Cognition, 2006) and as 
such the normative mean score for the SSRT outcome measure was derived 
from results of previous literature published in a peer reviewed journal 
(Chamberlain et al. 2007b) which reported mean SSRT score for 20 healthy 
adult subjects with no history of psychiatric or neurological illness. 
 Set-shifting - normative data for the CANTAB IED task were retrieved from 
Cambridge Cognition. This data had been obtained from over 2000 studies 
with normal subjects aged 4 to 90 years who participated in several studies 
conducted primarily in the United Kingdom (Cambridge Cognition, 2006). 
The normative data was stratified by age and as such for the purposes of the 
analysis above a single comparative normative mean was calculated for each 
IED outcome measure according the age ratio in the current clinical sample. 
 Theory of Mind - Normative data for the Mind in the Eyes task was taken 
from Baron-Cohen, wheelwright, Hill, Raste & Plumb’s (2001) study which 
determined mean normative scores based on the results of 122 healthy adult 
control participants.  
 General executive function – Normative data for the Modified Six Elements 
task of the BADS was taken from research published by the authors of the 
test who normed it on a group of 216 healthy adults (Wilson et al. 1996). 
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Appendix 8 – Correlation matrix – Mood, IQ and neurocognitive performance. 
Note. *Indicates p<0.05. **Indicates p<0.01. 
a
Indicates a possible trend p<0.1 
 
 
 
Appendix 9 – Correlation matrix – Mood, IQ and autistic traits (AQ scores). 
 AQ Total 
Score 
AQ-Social 
skills 
AQ-Attention 
Switching 
AQ-Attention to 
detail 
AQ-
Communication 
AQ- 
Imagination 
MADRS: 
 
r=.62** 
p=.00 
r=.54* 
p=.01 
r=.48* 
p=.03 
r=-.01 
p=.96 
r=.62** 
p=.00 
r=.39a 
p=.09 
 
STAI-
State:    
 
r=.28 
p=.24 
 
r=.42a 
p=.07 
 
r=.25 
p=.30 
 
r=.14 
p=.55 
 
r=.31 
p=.18 
 
r=-.16 
p=.49 
 
STAI-
Trait: 
 
r=.51* 
p=.02 
 
r=.37 
p=.11 
 
r=.29 
p=.21 
 
r=.24 
p=.31 
 
r=.39a 
p=.09 
 
r=.32 
p=.17 
 
WASI 
IQ: 
 
r=-.29 
p=.20 
 
r=-.05 
p=.84 
 
r=-.46* 
p=.04 
 
r=.10 
p=.69 
 
r=-.26 
p=.26 
 
r=-.32 
p=.16 
Note. *Indicates p<0.05. **Indicates p<0.01. 
a
Indicates a possible trend p<0.1 
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r=-.18 
p=.45 
r=-.21 
p=.39 
r=-.19 
p=.43 
r=-.18 
p=.44 
r=-.16 
p=.49 
r=-.18 
p=.46 
r=.19 
p=.43 
r=.27 
p=.25 
r=.38a 
p=.10 
r=-.39a 
p=.09 
r=.00 
p=.99 
S
T
A
I-
S
ta
te
: 
  
 
 
r=-.08 
p=.73 
 
r=.14 
p=.56 
 
r=.19 
p=.43 
 
r=-.23 
p=.34 
 
r=.25 
p=.29 
 
r=.19 
p=.42 
 
r=.18 
p=.44 
 
r=-.08 
p=.75 
 
r=.02 
p=.94 
 
r=.01 
p=.98 
 
r=.34 
p=.14 
S
T
A
I-
T
ra
it
:  
r=-.08 
p=.73 
 
r=-.15 
p=.52 
 
r=-.07 
p=.78 
 
r=-.23 
p=.34 
 
r=.19 
p=.41 
 
r=.09 
p=.72 
 
r=-.10 
p=.69 
 
r=.05 
p=.85 
 
r=.14 
p=.57 
 
r=-.13 
p=.58 
 
r=.22 
p=.35 
W
A
S
I 
IQ
: 
r=.27 
p=.25 
r=.45* 
p=.05 
r=.41 a 
p=.07 
r=-.01 
p=.98 
r=.56* 
p=.01 
r=.51* 
p=.02 
r=-.14 
p=.56 
r=-.38a 
p=.10 
r=-
.38a 
p=.10 
r=.35 
p=.13 
r=.38a 
p=.10 
